Healthcare Equipment & Supplies Sector Financials, Performance and Ratios
-
Sector Score
44.1 /100
Rank 10 out of 27 Sectors -
Advance/Decline
172/56
-
No. of Companies228
-
Avg. Market Cap8,846
-
Price to Earning Ratio29.14
-
Price to Earning Growth Ratio3.86
-
Price to Book Ratio12.36
-
Return on Equity24.54
-
Return on Capital Employed-
-
Return on Assets9.10
-
Dividend yield 1 year %0.20 %
-
Net Profit Growth Annual YoY %4.31 %
-
Net Profit Growth Qtr YoY %32.95 %
-
Net Profit Growth Qtr QoQ %11.61 %
Show more
*All values are market cap weighted averages.
*All Financial parameters are in Million USD.
Healthcare Equipment & Supplies Sector Market Breadth
- < -5%
- -2 to -5%
- 0 to -2%
- 0 to 2%
- 2 to 5%
- > 5%
Healthcare Equipment & Supplies Peer comparison
Compare all stocks in Healthcare Equipment & Supplies industry listed on stock exchanges
Stock Name | 3M Price Chart | Market Cap | LTPLast Traded Price | Day High Low (%) | Week High Low (%) | Month High Low (%) | Qtr High Low(%) | 1 Year High low(%) | 3 Year High low(%) | 5 Year High low(%) | 10 Year High low(%) |
---|---|---|---|---|---|---|---|---|---|---|---|
Agilent Technologies Inc. |
|
29,282.9
|
102.7
|
L
 2.8%
H
98.9
103.3
|
L
 -0.3%
H
96.4
107.3
|
L
 -15.1%
H
96.4
124.4
|
L
 -25.3%
H
96.4
153.8
|
L
 -29.2%
H
96.4
155.4
|
L
 -21.8%
H
96.4
160.3
|
L
 31.1%
H
73.4
179.6
|
L
 135.8%
H
33.1
179.6
|
Abbott Laboratories |
|
220,051.0
|
126.9
|
L
 1.9%
H
124.0
128.5
|
L
 2.0%
H
120.5
128.5
|
L
 -4.4%
H
120.5
133.6
|
L
 11.8%
H
110.9
141.2
|
L
 13.8%
H
99.7
141.2
|
L
 5.7%
H
89.7
141.2
|
L
 47.5%
H
83.5
142.6
|
L
 169.1%
H
36
142.6
|
Alcon Inc. - Registered Sh... |
|
44,322.6
|
89.6
|
L
 3%
H
88.0
89.9
|
L
 6.9%
H
80.5
90.5
|
L
 0.5%
H
80.5
97.4
|
L
 7.4%
H
80.5
97.4
|
L
 8.9%
H
77.5
101.1
|
L
 11.7%
H
55.2
101.1
|
L
 68.0%
H
49.7
101.1
|
L
H
39.4
101.1
|
Artivion Inc |
|
997.6
|
23.4
|
L
 -0.7%
H
22.8
23.6
|
L
 0.7%
H
22.0
24.6
|
L
 -0.5%
H
22.0
25.1
|
L
 -21.8%
H
22.0
32.3
|
L
 9.6%
H
19.4
32.3
|
L
 11.5%
H
9.6
32.3
|
L
 17.4%
H
9.6
32.3
|
L
 125.6%
H
8.9
36.1
|
Avanos Medical Inc |
|
573.7
|
12.5
|
L
 0.3%
H
12.2
12.6
|
L
 -7.1%
H
12.1
13.5
|
L
 -15.5%
H
12.1
15.0
|
L
 -18.0%
H
12.1
17.7
|
L
 -35.0%
H
12.1
25.4
|
L
 -60.8%
H
12.1
33.2
|
L
 -56.9%
H
12.1
53.6
|
L
 -74.9%
H
12.1
73.0
|
Baxter International Inc. |
|
14,279.8
|
27.8
|
L
 -1.1%
H
26.8
28.3
|
L
 -3.3%
H
26.3
30.8
|
L
 -22.3%
H
26.3
35.8
|
L
 -5.4%
H
26.3
37.7
|
L
 -33.9%
H
26.3
41.9
|
L
 -64.7%
H
26.3
79.6
|
L
 -68.0%
H
26.3
95.2
|
L
 -27.4%
H
26.3
95.2
|
Becton, Dickinson And Co. |
|
57,938.2
|
201.8
|
L
 1.3%
H
196.6
203.4
|
L
 -2.7%
H
193.0
211.8
|
L
 -10.3%
H
193.0
233.5
|
L
 -13.7%
H
193.0
251.9
|
L
 -16.1%
H
193.0
251.9
|
L
 -25.3%
H
193.0
287.3
|
L
 -16.4%
H
193.0
287.3
|
L
 44.4%
H
125.7
287.3
|
Butterfly Network Inc - Or... |
|
597.6
|
2.5
|
L
 7.4%
H
2.2
2.5
|
L
 20.6%
H
1.8
2.5
|
L
 -3.2%
H
1.8
2.9
|
L
 -31.5%
H
1.8
5.0
|
L
 159.0%
H
0.7
5.0
|
L
 -41.4%
H
0.7
8.7
|
L
H
0.7
29.1
|
L
H
0.7
29.1
|
Bio-Rad Laboratories Inc. ... |
|
6,885.1
|
245.8
|
L
 5.8%
H
231.7
246.1
|
L
 9.0%
H
215.4
249.6
|
L
 -2.1%
H
215.4
260.4
|
L
 -28.1%
H
215.4
373.7
|
L
 -21.2%
H
215.4
388.0
|
L
 -58.3%
H
215.4
595.5
|
L
 -37.5%
H
215.4
832.7
|
L
 77.1%
H
122.0
832.7
|
Bausch + Lomb Corp |
|
4,027.3
|
11.4
|
L
 0.7%
H
11.0
11.5
|
L
 -5.9%
H
10.5
12.6
|
L
 -26.6%
H
10.5
16.1
|
L
 -35.8%
H
10.5
18.1
|
L
 -24%
H
10.5
21.7
|
L
H
10.5
22.0
|
L
H
10.5
22.0
|
L
H
10.5
22.0
|
Boston Scientific Corp. |
|
138,544.5
|
93.7
|
L
 1.1%
H
91.9
94.5
|
L
 4.4%
H
86.0
97.7
|
L
 -1.9%
H
86.0
104.4
|
L
 -1.3%
H
86.0
107.2
|
L
 36.1%
H
66.8
107.2
|
L
 111.8%
H
35.0
107.2
|
L
 154.3%
H
33.0
107.2
|
L
 417.5%
H
14.2
107.2
|
Cardinal Health, Inc. |
|
31,831.4
|
131.8
|
L
 2.2%
H
128.4
132.8
|
L
 1.7%
H
120.7
132.8
|
L
 6.1%
H
120.7
139.5
|
L
 8.4%
H
119.3
139.5
|
L
 23.8%
H
93.2
139.5
|
L
 114.7%
H
49.7
139.5
|
L
 161.3%
H
44.7
139.5
|
L
 45.6%
H
39.1
139.5
|
Conmed Corp. |
|
1,600.0
|
51.7
|
L
 -1.1%
H
50.4
52.9
|
L
 -8.0%
H
50.4
58.5
|
L
 -16.5%
H
50.4
62.4
|
L
 -24.8%
H
50.4
74.7
|
L
 -32%
H
50.4
78.6
|
L
 -63.9%
H
50.4
155.5
|
L
 -28.4%
H
50.4
159.1
|
L
 5.0%
H
35.5
159.1
|
Cooper Companies, Inc. |
|
15,488.7
|
77.5
|
L
 2.8%
H
74.5
77.8
|
L
 5%
H
69.8
78.2
|
L
 -4.4%
H
69.8
85.3
|
L
 -14.2%
H
69.8
100.2
|
L
 -19.4%
H
69.8
112.4
|
L
 -23.9%
H
61.1
112.4
|
L
 4.5%
H
61.1
115.9
|
L
 65.5%
H
29.8
115.9
|
Danaher Corp. |
|
135,026.9
|
188.7
|
L
 4.4%
H
178.8
190.1
|
L
 3.8%
H
171.0
192.8
|
L
 -8.2%
H
171.0
215.4
|
L
 -19.7%
H
171.0
258.2
|
L
 -22.7%
H
171.0
281.7
|
L
 -35.2%
H
171.0
303.8
|
L
 29.5%
H
143.0
334.0
|
L
 193.0%
H
61.6
334.0
|
Edwards Lifesciences Corp |
|
40,651.4
|
69.4
|
L
 1.7%
H
67.1
69.8
|
L
 0.1%
H
65.9
71.2
|
L
 1.5%
H
65.9
73.3
|
L
 -5.5%
H
65.9
76.7
|
L
 -24.1%
H
58.9
95.3
|
L
 -42.9%
H
58.9
131.1
|
L
 -3.4%
H
58.9
131.7
|
L
 193.9%
H
20.5
131.7
|
Paragon 28 Inc |
|
1,090.3
|
13.0
|
L
 -0.2%
H
13.0
13.0
|
L
 -0.5%
H
13.0
13.1
|
L
 -0.2%
H
13.0
13.1
|
L
 25.5%
H
9.4
13.1
|
L
 24.1%
H
4.7
13.1
|
L
 -16.4%
H
4.7
21.5
|
L
H
4.7
25.4
|
L
H
4.7
25.4
|
Glaukos Corporation |
|
5,095.0
|
90.1
|
L
 0.5%
H
86.3
91.3
|
L
 7.7%
H
78.8
94.5
|
L
 -7.9%
H
77.9
108.6
|
L
 -42.5%
H
77.9
163.7
|
L
 -9.3%
H
77.9
163.7
|
L
 44.9%
H
33.3
163.7
|
L
 165.8%
H
31.4
163.7
|
L
H
14.3
163.7
|
Globus Medical Inc - Ordin... |
|
9,984.1
|
72.6
|
L
 2.3%
H
69.7
72.8
|
L
 5.5%
H
65.6
75.5
|
L
 -1.2%
H
65.6
77.0
|
L
 -16.6%
H
65.6
94.9
|
L
 38.4%
H
49.3
94.9
|
L
 -2.9%
H
43.4
94.9
|
L
 50.2%
H
42.9
94.9
|
L
 187.1%
H
19.3
94.9
|
Haemonetics Corp. |
|
3,016.3
|
60.0
|
L
 1.3%
H
57.9
60.3
|
L
 -1.4%
H
55.3
63.1
|
L
 -12.1%
H
55.3
68.4
|
L
 -21.7%
H
55.3
82.3
|
L
 -30.6%
H
55.3
98.0
|
L
 1.8%
H
48.7
98.0
|
L
 -40.2%
H
43.5
142.1
|
L
 34.1%
H
26.0
142.1
|
Herbalife Nutrition Ltd |
|
678.0
|
6.7
|
L
 -1.3%
H
6.3
6.8
|
L
 -19.1%
H
6.3
8.2
|
L
 -21.5%
H
6.3
8.9
|
L
 2.5%
H
5.0
9.2
|
L
 -19.4%
H
5.0
12.8
|
L
 -78.3%
H
5.0
31.4
|
L
 -77.9%
H
5.0
59
|
L
 -69.5%
H
5.0
61.8
|
Inspire Medical Systems Inc |
|
4,390.7
|
147.5
|
L
 2.1%
H
141.7
148.1
|
L
 4.0%
H
132.7
159.4
|
L
 -14.6%
H
132.7
176.5
|
L
 -27.1%
H
132.7
203.1
|
L
 -36.5%
H
123
257.4
|
L
 -42.3%
H
123
330
|
L
 128.4%
H
61.0
330
|
L
H
22.5
330
|
Integer Holdings Corp |
|
4,064.7
|
116.5
|
L
 2.4%
H
112.7
117.3
|
L
 2.5%
H
104.9
117.3
|
L
 -3.0%
H
104.9
121.8
|
L
 -12.9%
H
104.9
146.4
|
L
 -0.4%
H
104.9
146.4
|
L
 44.6%
H
50.1
146.4
|
L
 64.6%
H
50.1
146.4
|
L
 132.0%
H
18.1
146.4
|
Mckesson Corporation |
|
86,395.0
|
689.4
|
L
 1.5%
H
673.5
693.5
|
L
 0.9%
H
641.7
693.5
|
L
 5.5%
H
635
728.3
|
L
 18.5%
H
570.5
728.3
|
L
 31.7%
H
464.4
728.3
|
L
 115.0%
H
298.7
728.3
|
L
 417.1%
H
125.7
728.3
|
L
 207.3%
H
106.1
728.3
|
Medtronic Plc |
|
106,322.9
|
82.9
|
L
 0.4%
H
81.2
83.4
|
L
 0.0%
H
79.6
85.5
|
L
 -11.1%
H
79.6
93.7
|
L
 2.8%
H
79.6
96.3
|
L
 0.9%
H
76.0
96.3
|
L
 -25.7%
H
68.9
114.3
|
L
 -17.9%
H
68.9
135.9
|
L
 6.4%
H
55.5
135.9
|
Mettler-Toledo Internation... |
|
21,714.2
|
1,041.9
|
L
 4.4%
H
987.6
1048.5
|
L
 1.9%
H
946.7
1083.7
|
L
 -16.2%
H
946.7
1249
|
L
 -14.0%
H
946.7
1438.5
|
L
 -20.6%
H
946.7
1546.9
|
L
 -22.7%
H
928.5
1616.0
|
L
 43.2%
H
661.3
1714.8
|
L
 214.6%
H
275.3
1714.8
|
Envista Holdings Corp |
|
2,662.0
|
15.5
|
L
 -0.5%
H
15.1
15.7
|
L
 -0.1%
H
14.2
16.7
|
L
 -9.8%
H
14.2
18.0
|
L
 -16.8%
H
14.2
22.7
|
L
 -23.1%
H
14.2
23
|
L
 -66.6%
H
14.2
46.7
|
L
 -11.9%
H
14.2
52.0
|
L
H
10.1
52.0
|
Owens & Minor, Inc. |
|
533.1
|
6.9
|
L
 -1.4%
H
6.7
7.2
|
L
 -15.4%
H
6.7
9.8
|
L
 -27.7%
H
6.7
10.2
|
L
 -50.3%
H
6.1
15.5
|
L
 -73.4%
H
6.1
26.1
|
L
 -83.7%
H
6.1
44.8
|
L
 13.7%
H
6.1
49.2
|
L
 -79.5%
H
2.4
49.2
|
Penumbra Inc |
|
10,488.7
|
272.3
|
L
 1.4%
H
264.5
277.3
|
L
 3.8%
H
246.5
279.1
|
L
 3.8%
H
246.5
288.6
|
L
 8.7%
H
237.7
310
|
L
 22.4%
H
148
310
|
L
 35.9%
H
114.9
348.7
|
L
 67.3%
H
114.9
348.7
|
L
H
30
348.7
|
Koninklijke Philips N.V. -... |
|
21,654.5
|
23.4
|
L
 3.5%
H
22.9
23.6
|
L
 6.0%
H
21.5
24.0
|
L
 -12.5%
H
21.5
27.0
|
L
 -9.3%
H
21.5
28.7
|
L
 13.6%
H
19.9
32.9
|
L
 -23.0%
H
11.8
32.9
|
L
 -42.5%
H
11.8
61.2
|
L
 -17.9%
H
11.8
61.2
|
Qiagen NV |
|
9,072.6
|
42.0
|
L
 4.8%
H
40.8
42.4
|
L
 9.7%
H
38.6
42.4
|
L
 7.0%
H
38.1
42.4
|
L
 -8.7%
H
37.6
49.3
|
L
 -0.9%
H
37.6
49.3
|
L
 -17.7%
H
36.8
54.3
|
L
 -0.5%
H
36.8
62.6
|
L
 49.8%
H
22.0
62.6
|
Vicarious Surgical Inc - O... |
|
31.6
|
5.3
|
L
 -2.0%
H
5.2
5.6
|
L
 -4.5%
H
5
5.9
|
L
 -41.6%
H
5
9.7
|
L
 -57.3%
H
5
16.9
|
L
 -98.2%
H
4.3
396
|
L
 -99.9%
H
4.3
4608
|
L
H
4.3
14207.0
|
L
H
4.3
14207.0
|
Resmed Inc. |
|
31,428.1
|
214.0
|
L
 1.6%
H
206.7
214
|
L
 4.3%
H
199.9
218.9
|
L
 -5.2%
H
199.9
227
|
L
 -8.5%
H
199.9
263.1
|
L
 12.9%
H
172.2
263.1
|
L
 -11.6%
H
132.2
263.1
|
L
 33.9%
H
132.2
301.3
|
L
 186.0%
H
49.0
301.3
|
Steris Plc |
|
21,722.3
|
221.1
|
L
 1.8%
H
214.3
222.8
|
L
 4.0%
H
204.9
223.5
|
L
 -3.1%
H
204.9
229.1
|
L
 5.9%
H
204.3
236.8
|
L
 7.2%
H
197.8
248.2
|
L
 -10.6%
H
159.2
255.9
|
L
 44.8%
H
138.7
255.9
|
L
 212.9%
H
60.8
255.9
|
Stevanato Group Spa |
|
5,979.2
|
21.9
|
L
 6.2%
H
20.4
21.9
|
L
 15.2%
H
18.2
21.9
|
L
 3.6%
H
18.2
23
|
L
 -4.5%
H
17.8
23.7
|
L
 -24.5%
H
16.6
29.8
|
L
 11.4%
H
13.4
36.3
|
L
H
13.4
36.3
|
L
H
13.4
36.3
|
Stryker Corp. |
|
133,698.0
|
350.3
|
L
 0.5%
H
341.7
353.1
|
L
 1.3%
H
329.2
364.4
|
L
 -4.1%
H
329.2
380.9
|
L
 -4.2%
H
329.2
406.2
|
L
 1.2%
H
314.9
406.2
|
L
 33.0%
H
188.8
406.2
|
L
 91.7%
H
168.5
406.2
|
L
 273.7%
H
86.7
406.2
|
Smith & Nephew plc - ADR |
|
11,309.7
|
25.9
|
L
 3.2%
H
25.4
26.0
|
L
 -1.8%
H
23.9
26.4
|
L
 -13.4%
H
23.9
30.0
|
L
 7.9%
H
23.7
30.4
|
L
 5.4%
H
23.7
31.7
|
L
 -18.4%
H
21.5
34.1
|
L
 -36.0%
H
21.5
46.1
|
L
 -26.1%
H
21.5
52.3
|
Teleflex Incorporated |
|
5,803.5
|
129.9
|
L
 0.6%
H
125.5
130.5
|
L
 -1.6%
H
124.7
135.7
|
L
 -6.4%
H
124.7
143.3
|
L
 -25.6%
H
124.7
185.9
|
L
 -40.3%
H
124.7
249.9
|
L
 -61.7%
H
124.7
349.4
|
L
 -60.1%
H
124.7
449.4
|
L
 7.2%
H
118.8
449.4
|
Thermo Fisher Scientific Inc. |
|
165,398.2
|
438.2
|
L
 2.5%
H
420
440.7
|
L
 0.1%
H
409.9
455.0
|
L
 -14.8%
H
409.9
526.8
|
L
 -19.2%
H
409.9
611.0
|
L
 -23.7%
H
409.9
627.9
|
L
 -25.2%
H
409.9
627.9
|
L
 38.1%
H
309.2
672.3
|
L
 227.6%
H
117.1
672.3
|
Waters Corp. |
|
19,349.2
|
325.2
|
L
 3.4%
H
310
326.4
|
L
 0.1%
H
297.1
340.6
|
L
 -14.2%
H
297.1
384.0
|
L
 -14.5%
H
297.1
423.6
|
L
 -3.8%
H
279.2
423.6
|
L
 7.5%
H
231.9
423.6
|
L
 66.0%
H
171.4
428.2
|
L
 158.6%
H
112
428.2
|
West Pharmaceutical Servic... |
|
15,232.1
|
210.7
|
L
 3.4%
H
200.7
211.5
|
L
 3.7%
H
187.4
211.5
|
L
 -8.7%
H
187.4
235.6
|
L
 -36.5%
H
187.4
348.9
|
L
 -45.6%
H
187.4
394.4
|
L
 -47.1%
H
187.4
415.7
|
L
 29.3%
H
156.9
475.4
|
L
 273.6%
H
52.7
475.4
|
Zimmer Biomet Holdings Inc |
|
20,374.1
|
102.4
|
L
 0.1%
H
99
102.9
|
L
 -4.7%
H
98.9
108.5
|
L
 -4.7%
H
98.9
114.4
|
L
 -2.1%
H
97.7
114.4
|
L
 -19.7%
H
97.7
127.3
|
L
 -19.3%
H
97.7
149.3
|
L
 -1.5%
H
97.7
169.7
|
L
 -7.4%
H
70.0
169.7
|
Bio-Rad Laboratories Inc. ... |
|
6,485.9
|
225.3
|
L
H
225.3
225.3
|
L
 -6.9%
H
225.3
225.3
|
L
 -15.3%
H
225.3
242.0
|
L
 -33.9%
H
225.3
359.2
|
L
 -33.5%
H
225.3
373.4
|
L
 -32.2%
H
225.3
373.4
|
L
 -32.2%
H
225.3
373.4
|
L
 -32.2%
H
225.3
373.4
|
Haleon plc - ADR |
|
45,413.8
|
10.1
|
L
 4.5%
H
9.8
10.1
|
L
 1.7%
H
9.2
10.1
|
L
 -3.2%
H
9.2
10.6
|
L
 10.6%
H
8.9
10.8
|
L
 23.1%
H
8.0
10.8
|
L
H
5.6
10.8
|
L
H
5.6
10.8
|
L
H
5.6
10.8
|
Revvity Inc. |
|
11,397.2
|
94.9
|
L
 2.0%
H
91.8
95.5
|
L
 0.0%
H
89.6
101.9
|
L
 -16.0%
H
89.6
114.6
|
L
 -16.7%
H
89.6
128.3
|
L
 -12.6%
H
89.6
129.5
|
L
 -42.8%
H
79.5
170
|
L
 21.1%
H
75.7
203.2
|
L
 84.1%
H
39.5
203.2
|
Aethlon Medical Inc |
|
7.0
|
0.3
|
L
H
0.3
0.3
|
L
 -2.9%
H
0.3
0.4
|
L
 -24.4%
H
0.3
0.5
|
L
 -50%
H
0.3
0.8
|
L
 -78.2%
H
0.2
1.8
|
L
 -97.2%
H
0.2
24.6
|
L
 -97.5%
H
0.2
124.9
|
L
 -100.0%
H
0.2
2287.5
|
Acutus Medical Inc |
|
1.2
|
0.0
|
L
H
0.0
0.0
|
L
H
0.0
0.0
|
L
H
0.0
0.1
|
L
 -33.3%
H
0.0
0.1
|
L
 -77.8%
H
0.0
0.2
|
L
 -96%
H
0.0
2.2
|
L
H
0.0
39.0
|
L
H
0.0
39.0
|
Ainos Inc |
|
9.9
|
0.6
|
L
 23.1%
H
0.5
0.7
|
L
 23.1%
H
0.5
0.7
|
L
 36.2%
H
0.4
0.7
|
L
 -9.9%
H
0.4
1.0
|
L
 -37.9%
H
0.4
1.5
|
L
 -91.6%
H
0.4
18
|
L
H
0
71.3
|
L
H
0
71.3
|
Airsculpt Technologies Inc |
|
106.6
|
1.8
|
L
 1.1%
H
1.8
1.9
|
L
 -8.1%
H
1.7
2.2
|
L
 -38.1%
H
1.7
3.3
|
L
 -69.6%
H
1.7
6.1
|
L
 -67.7%
H
1.7
9.2
|
L
 -85.0%
H
1.7
12.9
|
L
H
1.7
18.5
|
L
H
1.7
18.5
|
Align Technology, Inc. |
|
12,016.7
|
164.1
|
L
 2.5%
H
156.8
165.5
|
L
 6.9%
H
141.7
168.0
|
L
 -0.6%
H
141.7
172.8
|
L
 -21.8%
H
141.7
237.2
|
L
 -49.5%
H
141.7
327.5
|
L
 -59.9%
H
141.7
431.3
|
L
 -15.0%
H
141.7
737.5
|
L
 202.3%
H
52.0
737.5
|
Angiodynamic Inc |
|
377.2
|
9.3
|
L
 0.5%
H
9.0
9.5
|
L
 2.0%
H
8.7
9.9
|
L
 1.9%
H
8.7
11.7
|
L
 -24.4%
H
8.3
13.5
|
L
 36.6%
H
5.5
13.5
|
L
 -58.7%
H
5.3
24.9
|
L
 -11.3%
H
5.3
32
|
L
 -43.8%
H
5.3
32
|
Anika Therapeutics Inc. |
|
193.4
|
13.6
|
L
 0.3%
H
13.1
13.7
|
L
 -2.6%
H
12.8
14.5
|
L
 -18.8%
H
12.8
17.1
|
L
 -12.4%
H
12.8
18.4
|
L
 -46.7%
H
12.8
29.1
|
L
 -43.0%
H
12.8
32.5
|
L
 -58.5%
H
12.8
48.4
|
L
 -66.5%
H
12.8
75.7
|
Apyx Medical Corp |
|
36.3
|
1.0
|
L
 9.1%
H
0.9
1
|
L
 -3.0%
H
0.9
1.2
|
L
 -9.4%
H
0.8
1.4
|
L
 -39.6%
H
0.8
1.8
|
L
 -38.1%
H
0.8
2.0
|
L
 -82.7%
H
0.8
11.2
|
L
 -75.8%
H
0.8
17.5
|
L
 -60.5%
H
0.8
17.5
|
Accuray Inc |
|
150.1
|
1.5
|
L
 -1.4%
H
1.4
1.5
|
L
 -7.0%
H
1.4
1.7
|
L
 -19.8%
H
1.4
1.9
|
L
 -30.5%
H
1.4
3.0
|
L
 -37.6%
H
1.4
3.0
|
L
 -54.2%
H
1.4
4.3
|
L
 -27%
H
1.4
6.0
|
L
 -85.1%
H
1.3
10.0
|
Alphatec Holdings Inc |
|
1,405.5
|
9.8
|
L
 2.3%
H
9.3
9.8
|
L
 -4.7%
H
8.8
10.7
|
L
 -2.0%
H
8.8
10.7
|
L
 -2.2%
H
8.8
12.8
|
L
 -29.3%
H
4.9
13.8
|
L
 -19.6%
H
4.9
19.1
|
L
 147.5%
H
3.4
19.4
|
L
 -43.2%
H
1.2
19.4
|
Atricure Inc |
|
1,587.3
|
32.1
|
L
 1.4%
H
31.1
32.6
|
L
 2.4%
H
29.5
34.3
|
L
 -5.5%
H
29.5
35.6
|
L
 2.1%
H
29.5
43.1
|
L
 26.7%
H
18.9
43.1
|
L
 -45.7%
H
18.9
62.3
|
L
 -11.5%
H
18.9
89.2
|
L
 47.8%
H
13.4
89.2
|
Avinger Inc |
|
1.5
|
0.5
|
L
H
0.5
0.5
|
L
H
0.5
0.5
|
L
H
0.5
0.5
|
L
 -16.1%
H
0.4
0.8
|
L
 -89.0%
H
0.4
4.4
|
L
 -98.9%
H
0.4
49.5
|
L
 -99.6%
H
0.4
801
|
L
 -100.0%
H
0.4
3013200
|
Accelerate Diagnostics Inc |
|
14.0
|
0.6
|
L
 -3.5%
H
0.5
0.6
|
L
 -13.9%
H
0.5
0.7
|
L
 -50.9%
H
0.5
1.2
|
L
 -53.3%
H
0.5
1.4
|
L
 -37.8%
H
0.5
2.1
|
L
 -94.9%
H
0.5
37.4
|
L
 -99.4%
H
0.5
191.1
|
L
 -99.7%
H
0.5
312.9
|
Axogen Inc. |
|
704.6
|
15.9
|
L
 0.6%
H
15.2
16.2
|
L
 -2.0%
H
15.2
17.3
|
L
 -8.8%
H
15.2
19.5
|
L
 -12.0%
H
15.2
21
|
L
 116.5%
H
5.6
21
|
L
 123.2%
H
3.5
21
|
L
 96.2%
H
3.5
23.9
|
L
 370.1%
H
3.0
56.9
|
Bone Biologics Corp |
|
2.4
|
0.7
|
L
 7.3%
H
0.7
0.8
|
L
 2.8%
H
0.6
0.8
|
L
 -11.9%
H
0.6
0.9
|
L
 -27.5%
H
0.6
1.3
|
L
 -55.7%
H
0.6
4.3
|
L
 -99.9%
H
0.6
628.8
|
L
 -100.0%
H
0.6
4500.1
|
L
H
0.6
35400
|
BioAffinity Technologies Inc |
|
9.7
|
0.5
|
L
 -3.6%
H
0.5
0.6
|
L
 -20.6%
H
0.5
0.8
|
L
 50%
H
0.2
1.6
|
L
 -33.3%
H
0.2
1.6
|
L
 -77.0%
H
0.2
3.2
|
L
H
0.2
15.6
|
L
H
0.2
15.6
|
L
H
0.2
15.6
|
Bluejay Diagnostics Inc |
|
1.5
|
2.6
|
L
 2.3%
H
2.5
2.8
|
L
 -25.2%
H
2.2
10.2
|
L
 -34.5%
H
2.2
10.2
|
L
 -27.7%
H
2.2
10.2
|
L
 -50.1%
H
0.1
10.2
|
L
 -98.5%
H
0.1
292.8
|
L
H
0.1
1000
|
L
H
0.1
1000
|
Biolife Solutions Inc |
|
1,041.3
|
21.9
|
L
 4.3%
H
20.5
22.0
|
L
 4.9%
H
19.1
23.7
|
L
 -17.7%
H
19.1
27.1
|
L
 -17.7%
H
19.1
29.5
|
L
 28.1%
H
14.8
29.5
|
L
 10.4%
H
8.9
29.5
|
L
 129.8%
H
8.9
60.7
|
L
 1211.4%
H
1.4
60.7
|
Biomerica Inc. |
|
9.9
|
0.5
|
L
 5.9%
H
0.5
0.6
|
L
 8%
H
0.5
0.6
|
L
 -11.5%
H
0.5
0.7
|
L
 54.3%
H
0.3
1.3
|
L
 -33.3%
H
0.2
1.3
|
L
 -87.4%
H
0.2
5.3
|
L
 -92.8%
H
0.2
12.8
|
L
 -31.6%
H
0.2
23.4
|
Bruker Corp |
|
5,880.1
|
38.8
|
L
 1.8%
H
37.3
39
|
L
 6.3%
H
35
41.3
|
L
 -14.9%
H
34.1
47.4
|
L
 -36.2%
H
34.1
64.6
|
L
 -57.1%
H
34.1
90.0
|
L
 -39.0%
H
34.1
94.9
|
L
 5.3%
H
34.1
94.9
|
L
 92.1%
H
15.8
94.9
|
BioRestorative Therapies Inc |
|
12.4
|
1.8
|
L
 2.9%
H
1.7
1.8
|
L
 5.3%
H
1.6
1.8
|
L
 11.9%
H
1.5
2.1
|
L
 9.8%
H
1.4
2.6
|
L
 35.6%
H
1.0
2.6
|
L
 -68.1%
H
1.0
7.1
|
L
 347.5%
H
0.4
185.6
|
L
 -100.0%
H
0.4
49000
|
Biosig Technologies Inc |
|
13.8
|
0.6
|
L
 -3.3%
H
0.6
0.6
|
L
 11.5%
H
0.4
0.7
|
L
 -21.6%
H
0.4
0.8
|
L
 -59.7%
H
0.4
1.5
|
L
 -61.1%
H
0.2
2.6
|
L
 -43.7%
H
0.1
3.0
|
L
 -88.8%
H
0.1
12.4
|
L
 -95.0%
H
0.1
12.4
|
Bioventus Inc - Ordinary S... |
|
494.9
|
7.5
|
L
 -1.2%
H
7.1
7.7
|
L
 -10.2%
H
7.1
8.7
|
L
 -30.7%
H
7.1
10.8
|
L
 -19.4%
H
7.1
11.3
|
L
 55.5%
H
3.9
14.4
|
L
 -42.0%
H
0.8
14.4
|
L
H
0.8
19.9
|
L
H
0.8
19.9
|
Brainsway Ltd - ADR |
|
159.6
|
8.5
|
L
 0.4%
H
8.1
8.5
|
L
 -4.4%
H
8
9.2
|
L
 -12.1%
H
8
10.5
|
L
 -10%
H
8
11.8
|
L
 59.6%
H
4.6
11.8
|
L
 -1.3%
H
1.4
11.8
|
L
 4.2%
H
1.4
11.8
|
L
H
1.4
12.5
|
Cardio Diagnostics Holding... |
|
20.9
|
0.4
|
L
 17.7%
H
0.3
0.4
|
L
 29.0%
H
0.3
0.4
|
L
H
0.3
0.5
|
L
 -40.3%
H
0.3
0.7
|
L
 -63.0%
H
0.2
1.8
|
L
 -96.0%
H
0.2
10.3
|
L
H
0.2
10.3
|
L
H
0.2
10.3
|
Caredx Inc |
|
1,042.6
|
18.8
|
L
 2.1%
H
17.8
18.9
|
L
 8.9%
H
15.8
20.1
|
L
 2.2%
H
15.8
20.1
|
L
 -20.4%
H
15.8
26.0
|
L
 105.8%
H
7.4
34.8
|
L
 -48.3%
H
4.8
39.0
|
L
 -14.1%
H
4.8
99.8
|
L
 258.3%
H
0.8
99.8
|
Celcuity Inc |
|
349.3
|
9.2
|
L
 6.7%
H
8.5
9.3
|
L
 6.7%
H
7.6
9.7
|
L
 -10.7%
H
7.6
11.2
|
L
 -22.6%
H
7.6
13.4
|
L
 -53.1%
H
7.6
19.8
|
L
 22.7%
H
4.8
22.2
|
L
 69.4%
H
4.0
33.0
|
L
H
4.0
33.0
|
Creative Medical Technolog... |
|
5.6
|
2.2
|
L
 22.2%
H
1.7
2.2
|
L
 -4.8%
H
1.7
2.4
|
L
 -42.4%
H
1.7
4.3
|
L
 1.4%
H
1.7
6.9
|
L
 -59.7%
H
1.7
6.9
|
L
 -93.2%
H
1.7
32.3
|
L
 -92.7%
H
1.7
650
|
L
H
1.7
525000
|
Cerus Corp. |
|
256.4
|
1.4
|
L
 11.3%
H
1.2
1.4
|
L
 11.3%
H
1.1
1.4
|
L
 -7.4%
H
1.1
1.6
|
L
 -12.7%
H
1.1
2.2
|
L
 -18.8%
H
1.1
2.5
|
L
 -72.6%
H
1.1
6.0
|
L
 -73.5%
H
1.1
8.9
|
L
 -64.6%
H
1.1
8.9
|
Check-Cap Ltd |
|
4.0
|
0.7
|
L
 -4.2%
H
0.7
0.7
|
L
 1.5%
H
0.6
0.7
|
L
 -8.1%
H
0.6
0.9
|
L
 -55.6%
H
0.6
1.7
|
L
 -71.7%
H
0.6
3.0
|
L
 -91.0%
H
0.6
9.2
|
L
 -96.2%
H
0.6
89.8
|
L
 -99.9%
H
0.6
284544
|
CollPlant Biotechnologies ... |
|
27.9
|
2.4
|
L
 -0.8%
H
2.3
2.4
|
L
 -0.8%
H
2.2
2.5
|
L
 -20.8%
H
2.2
3.7
|
L
 -41.9%
H
2.2
4.3
|
L
 -53.3%
H
2.2
6.8
|
L
 -75.2%
H
2.2
14.0
|
L
 -75.7%
H
2.2
24.3
|
L
H
2.2
27.9
|
ClearPoint Neuro Inc |
|
316.9
|
11.5
|
L
 2.9%
H
10.8
11.5
|
L
 4.0%
H
9.8
12.4
|
L
 -9.7%
H
9.8
14.0
|
L
 -21.9%
H
9.8
19.2
|
L
 85%
H
5.1
19.2
|
L
 11.8%
H
4.1
19.2
|
L
 239.3%
H
2.9
31.3
|
L
 -72.7%
H
1.3
58.4
|
Cardiff Oncology Inc |
|
164.3
|
2.5
|
L
 3.8%
H
2.4
2.6
|
L
 -10.2%
H
2.4
2.9
|
L
 -31.0%
H
2.4
4.4
|
L
 -31.6%
H
2.4
5.0
|
L
 -56.4%
H
2.0
5.9
|
L
 16.0%
H
0.9
6.4
|
L
 171.4%
H
0.8
25.5
|
L
 -99.5%
H
0.7
977.8
|
Castle Biosciences Inc |
|
568.2
|
19.7
|
L
 2.1%
H
19.1
20.0
|
L
 6.1%
H
17.5
20.8
|
L
 0.8%
H
17.5
21.1
|
L
 -34.9%
H
17.5
29.9
|
L
 -5.2%
H
17.0
35.8
|
L
 -36.3%
H
9.3
36.1
|
L
 -29.8%
H
9.3
107.7
|
L
H
9.3
107.7
|
Cytek BioSciences Inc |
|
475.2
|
3.7
|
L
 5.4%
H
3.5
3.7
|
L
H
3.3
3.9
|
L
 -13.3%
H
3.3
4.5
|
L
 -45.6%
H
3.3
7.3
|
L
 -41.1%
H
3.3
7.6
|
L
 -63.9%
H
3.3
16.1
|
L
H
3.3
28.7
|
L
H
3.3
28.7
|
Cytosorbents Corp |
|
60.6
|
1.0
|
L
 3.2%
H
0.9
1.0
|
L
H
0.9
1.0
|
L
 -3%
H
0.9
1.2
|
L
 3.2%
H
0.9
1.6
|
L
 7.8%
H
0.7
1.6
|
L
 -67.1%
H
0.7
4.6
|
L
 -85.3%
H
0.7
11.7
|
L
 -88.2%
H
0.7
15.0
|
Citius Pharmaceuticals Inc |
|
8.8
|
0.9
|
L
 -2.1%
H
0.9
1
|
L
 -7.8%
H
0.9
1.1
|
L
 -41.6%
H
0.9
2.3
|
L
 -74.1%
H
0.9
3.8
|
L
 -95.5%
H
0.1
26.3
|
L
 -97.6%
H
0.1
42.8
|
L
 -94.4%
H
0.1
114
|
L
 -99.9%
H
0.1
937.5
|
CVRx Inc |
|
162.2
|
6.2
|
L
 -3.9%
H
6.1
6.6
|
L
 -46.8%
H
5.9
12.4
|
L
 -46.1%
H
5.9
13.3
|
L
 -56.0%
H
5.9
18.6
|
L
 -65.6%
H
5.9
18.6
|
L
 16.2%
H
4.6
33.1
|
L
H
4.6
33.1
|
L
H
4.6
33.1
|
Delcath Systems Inc |
|
356.4
|
10.7
|
L
 1.2%
H
10.1
10.8
|
L
 -3.2%
H
9.8
11.6
|
L
 -9.7%
H
9.8
14.6
|
L
 -7.1%
H
9.8
17.0
|
L
 113.2%
H
4.3
17.0
|
L
 66.3%
H
2.3
17.0
|
L
 -12.6%
H
2.3
25.2
|
L
 -100.0%
H
2.3
3763200000
|
Alpha Tau Medical Ltd |
|
179.5
|
2.6
|
L
 2%
H
2.5
2.6
|
L
 1.2%
H
2.4
2.6
|
L
 -1.9%
H
2.3
2.9
|
L
 -21.1%
H
2.3
4.4
|
L
 -10.8%
H
1.8
4.4
|
L
 -74.4%
H
1.8
12.5
|
L
H
1.8
20.7
|
L
H
1.8
20.7
|
Dexcom Inc |
|
25,934.0
|
66.1
|
L
 -1.7%
H
65.0
67.7
|
L
 10.6%
H
58
73.5
|
L
 -5.9%
H
57.5
76.3
|
L
 -14.9%
H
57.5
93.2
|
L
 -52.6%
H
57.5
139.2
|
L
 -46.3%
H
57.5
142
|
L
 -3.9%
H
57.5
164.9
|
L
 289.7%
H
10.7
164.9
|
Daxor Corp. |
|
39.7
|
8.1
|
L
 3.2%
H
7.9
8.3
|
L
 5.4%
H
7.2
8.3
|
L
 3.3%
H
7.2
8.8
|
L
 -2.1%
H
6.6
9.0
|
L
 -16.6%
H
6.6
10
|
L
 -28.8%
H
6.6
14.6
|
L
 -42.0%
H
6.6
24.1
|
L
 3.7%
H
3.4
24.1
|
Dynatronics Corp. |
|
1.1
|
0.1
|
L
 20%
H
0.1
0.1
|
L
 9.1%
H
0.1
0.1
|
L
 -7.7%
H
0.1
0.1
|
L
 -14.3%
H
0.1
0.2
|
L
 -70%
H
0.1
0.6
|
L
 -96.8%
H
0.1
4.3
|
L
 -96.8%
H
0.1
12.8
|
L
 -99.2%
H
0.1
22.2
|
ElectroCore Inc |
|
40.1
|
5.6
|
L
 0.9%
H
5.2
5.8
|
L
 -1.6%
H
5.0
6.4
|
L
 -57.7%
H
5.0
14
|
L
 -66.3%
H
5.0
19.5
|
L
 -7.0%
H
5.0
19.5
|
L
 -24.1%
H
2.9
19.5
|
L
 -54.6%
H
2.9
54.5
|
L
H
2.9
303.8
|
Ekso Bionics Holdings Inc |
|
8.9
|
0.4
|
L
H
0.4
0.4
|
L
 -5.3%
H
0.3
0.4
|
L
 -5.3%
H
0.3
0.5
|
L
 -54.4%
H
0.3
0.8
|
L
 -72.1%
H
0.3
1.5
|
L
 -87.0%
H
0.3
3.1
|
L
 -87.1%
H
0.3
15.0
|
L
 -99.8%
H
0.3
219.5
|
Embecta Corp |
|
715.1
|
12.3
|
L
 2.4%
H
11.6
12.3
|
L
 2.5%
H
11.2
12.7
|
L
 -14.1%
H
11.2
14.4
|
L
 -36.9%
H
11.2
20.6
|
L
 11.7%
H
9.9
21.5
|
L
 -62.1%
H
9.9
36.6
|
L
H
9.9
63
|
L
H
9.9
63
|
Establishment Labs Holding... |
|
877.1
|
30.3
|
L
 0.7%
H
28.9
31
|
L
 -6.1%
H
26.6
34.9
|
L
 -15.2%
H
26.6
42.4
|
L
 -33.7%
H
26.6
46.7
|
L
 -42.8%
H
26.6
60.1
|
L
 -52.6%
H
17
93.8
|
L
 111.6%
H
13.3
93.8
|
L
H
7.6
93.8
|
Exact Sciences Corp. |
|
8,256.8
|
44.5
|
L
 1.6%
H
42.2
44.5
|
L
 4.5%
H
40.0
46.5
|
L
 -3.1%
H
40.0
47.2
|
L
 -21.3%
H
40.0
60.9
|
L
 -39.1%
H
40.0
73.1
|
L
 -33.2%
H
29.3
100.8
|
L
 -33.7%
H
29.3
159.5
|
L
 95.3%
H
4.7
159.5
|
EDAP TMS S.A. - ADR |
|
53.1
|
1.4
|
L
 -2.1%
H
1.4
1.5
|
L
 -11.8%
H
1.3
1.8
|
L
 -40.6%
H
1.3
2.6
|
L
 -32.4%
H
1.3
2.9
|
L
 -81.9%
H
1.3
7.9
|
L
 -80.4%
H
1.3
12.7
|
L
 -36.3%
H
1.3
12.7
|
L
 -57.9%
H
1.3
12.7
|
GlucoTrack Inc |
|
2.1
|
0.2
|
L
 -5.9%
H
0.2
0.2
|
L
 -5.9%
H
0.1
0.2
|
L
 -55.6%
H
0.1
0.5
|
L
 -93.2%
H
0.1
3.7
|
L
 -99.6%
H
0.1
99
|
L
 -99.9%
H
0.1
375
|
L
 -100.0%
H
0.1
780
|
L
 -100.0%
H
0.1
9750
|
GE HealthCare Technologies... |
|
28,757.1
|
62.8
|
L
 0.9%
H
60.9
63.6
|
L
 3.8%
H
57.7
65.5
|
L
 -26.6%
H
57.7
86.1
|
L
 -25.9%
H
57.7
94.8
|
L
 -28.8%
H
57.7
94.8
|
L
H
53
94.8
|
L
H
53
94.8
|
L
H
53
94.8
|
Harvard Bioscience Inc. |
|
17.6
|
0.4
|
L
 2.6%
H
0.4
0.4
|
L
H
0.4
0.5
|
L
 -47.4%
H
0.4
0.8
|
L
 -79.0%
H
0.4
2.1
|
L
 -90.8%
H
0.4
4.5
|
L
 -93.6%
H
0.4
6.3
|
L
 -83.9%
H
0.4
8.8
|
L
 -93.9%
H
0.4
8.8
|
Hologic, Inc. |
|
13,058.1
|
57.9
|
L
 1.2%
H
56.3
58.2
|
L
 -5.0%
H
56.3
62.4
|
L
 -7.6%
H
56.3
63
|
L
 -19.2%
H
56.3
73.1
|
L
 -25.6%
H
56.3
84.7
|
L
 -24.4%
H
56.3
87.9
|
L
 40.7%
H
39.8
87.9
|
L
 73.7%
H
26.5
87.9
|
Heart Test Laboratories Inc |
|
3.7
|
3.5
|
L
 -1.4%
H
3.2
3.6
|
L
 27.3%
H
2.7
3.6
|
L
 18.2%
H
2.6
3.6
|
L
 1.5%
H
2.6
4.1
|
L
 -67.7%
H
2.4
13.5
|
L
H
2.4
600
|
L
H
2.4
600
|
L
H
2.4
600
|
Helius Medical Technologie... |
|
1.7
|
0.3
|
L
 -6.3%
H
0.3
0.3
|
L
 -23.1%
H
0.3
0.4
|
L
 -28.6%
H
0.3
0.5
|
L
 -53.9%
H
0.3
1.6
|
L
 -95%
H
0.3
6.2
|
L
 -99.8%
H
0.3
175
|
L
 -99.9%
H
0.3
1700
|
L
 -100.0%
H
0.3
36225
|
Henry Schein Inc. |
|
7,897.1
|
64.5
|
L
 1.4%
H
62.0
66.5
|
L
 -1.5%
H
60.6
66.5
|
L
 -11.6%
H
60.6
72.9
|
L
 -7.5%
H
60.6
82.5
|
L
 -10.2%
H
60.6
82.5
|
L
 -28.5%
H
60.0
92.7
|
L
 23.4%
H
49.8
92.7
|
L
 15.9%
H
41.9
92.7
|
Hyperfine Inc - Ordinary S... |
|
56.8
|
0.7
|
L
 9.0%
H
0.7
0.7
|
L
 10.6%
H
0.6
0.7
|
L
 -18.9%
H
0.6
1.4
|
L
 -22.3%
H
0.6
1.9
|
L
 -27%
H
0.6
1.9
|
L
 -79.3%
H
0.6
4.1
|
L
H
0.6
16.6
|
L
H
0.6
16.6
|
Integra Lifesciences Holdi... |
|
1,312.5
|
17.0
|
L
 -2.5%
H
16.0
17.5
|
L
 -13.2%
H
16.0
20.5
|
L
 -29.1%
H
16.0
24.4
|
L
 -22.1%
H
16.0
27.1
|
L
 -48.8%
H
16.0
33.0
|
L
 -73.1%
H
16.0
65.7
|
L
 -65.2%
H
16.0
77.4
|
L
 -39.1%
H
16.0
77.4
|
Icad Inc |
|
48.7
|
1.8
|
L
 6.6%
H
1.7
1.8
|
L
 1.7%
H
1.6
1.8
|
L
 -19.5%
H
1.6
2.5
|
L
 -6.3%
H
1.6
3.8
|
L
 4.7%
H
1.2
3.8
|
L
 -52.3%
H
1.1
4.7
|
L
 -80.7%
H
1.1
21.4
|
L
 -80.5%
H
1.1
21.4
|
Icecure Medical Ltd |
|
65.7
|
1.1
|
L
 -2.6%
H
1.1
1.2
|
L
 -1.8%
H
1.1
1.2
|
L
 -14.5%
H
1.0
1.5
|
L
 -13.9%
H
1.0
1.7
|
L
 -10.4%
H
0.5
1.7
|
L
 -48.9%
H
0.5
4.7
|
L
 7.7%
H
0.2
16
|
L
 -45.9%
H
0.2
16
|
SeaStar Medical Holding Corp |
|
11.4
|
1.3
|
L
 3.2%
H
1.2
1.3
|
L
 -5.8%
H
1.1
1.5
|
L
 -32.1%
H
1.1
2.6
|
L
 -34.2%
H
1.1
3.1
|
L
 -92.7%
H
0.2
20
|
L
 -99.5%
H
0.2
550
|
L
H
0.2
550
|
L
H
0.2
550
|
ICU Medical, Inc. |
|
3,510.6
|
142.7
|
L
 3.1%
H
135.5
144.4
|
L
 2.4%
H
130.1
152.4
|
L
 2.6%
H
130.1
153.1
|
L
 -9.4%
H
127.0
175.5
|
L
 41.6%
H
93.4
196.3
|
L
 -35.7%
H
78.4
233.9
|
L
 -31.4%
H
78.4
282
|
L
 53.8%
H
78.4
321.7
|
Idexx Laboratories, Inc. |
|
31,681.4
|
390.9
|
L
 2.4%
H
375.1
392.5
|
L
 -0.7%
H
356.3
398.7
|
L
 -8.4%
H
356.3
430.2
|
L
 -6.5%
H
356.3
474.7
|
L
 -22.3%
H
356.3
548.9
|
L
 -24.0%
H
317.1
583.4
|
L
 51.2%
H
246.4
707.0
|
L
 409.2%
H
61.4
707.0
|
Inspira Technologies Oxy B... |
|
15.9
|
0.6
|
L
H
0.6
0.6
|
L
 5.1%
H
0.5
0.7
|
L
 -20.5%
H
0.5
0.8
|
L
 -39.2%
H
0.5
1.1
|
L
 -70.6%
H
0.5
2.5
|
L
 -74.9%
H
0.5
2.7
|
L
H
0.5
9.6
|
L
H
0.5
9.6
|
Intercure Ltd |
|
58.5
|
1.2
|
L
 1.6%
H
1.2
1.3
|
L
 -3.1%
H
1.2
1.4
|
L
 -20.5%
H
1.2
1.6
|
L
 -26.2%
H
1.2
1.8
|
L
 -49.0%
H
1.2
3.7
|
L
 -80.7%
H
1.0
7.6
|
L
 -75.3%
H
1.0
12.7
|
L
H
1.0
19.4
|
Inogen Inc |
|
196.5
|
7.3
|
L
 3.3%
H
7.0
7.4
|
L
 3.8%
H
6.4
7.4
|
L
 -5.3%
H
6.4
8.2
|
L
 -23.5%
H
6.4
12.9
|
L
 0.4%
H
6.4
13.3
|
L
 -76.4%
H
4.1
32.3
|
L
 -86.4%
H
4.1
82.4
|
L
 -79.0%
H
4.1
287.8
|
Inmode Ltd |
|
1,009.9
|
14.9
|
L
 5.5%
H
13.7
15.1
|
L
 -5.3%
H
13.7
16.3
|
L
 -20.9%
H
13.7
19.1
|
L
 -6.4%
H
13.7
19.8
|
L
 -19.4%
H
13.7
19.9
|
L
 -53.6%
H
13.7
48.3
|
L
 21.5%
H
10.8
99.3
|
L
H
6.5
99.3
|
NAYA Biosciences |
|
1.2
|
2.1
|
L
 20.9%
H
1.7
2.1
|
L
 13.7%
H
1.4
2.8
|
L
 -44.1%
H
1.4
4.3
|
L
 -78.7%
H
1.4
8.4
|
L
 -81.6%
H
1.4
42
|
L
 -99.6%
H
1.4
516
|
L
 -99.8%
H
1.4
2952
|
L
 -99.9%
H
1.4
11443.2
|
IRIDEX Corp. |
|
15.6
|
0.9
|
L
 -1.1%
H
0.9
1.0
|
L
 9.3%
H
0.8
1
|
L
 -23.6%
H
0.8
1.4
|
L
 -43.0%
H
0.8
1.7
|
L
 -73.1%
H
0.8
3.5
|
L
 -78.3%
H
0.8
4.5
|
L
 -50%
H
0.8
9.7
|
L
 -90.7%
H
0.8
16.6
|
Iradimed Corp |
|
664.9
|
52.3
|
L
 4.4%
H
49.3
52.5
|
L
 4.8%
H
47.5
53.0
|
L
 0.0%
H
47.5
54.1
|
L
 -7.6%
H
47.5
63.3
|
L
 24.5%
H
40.2
63.3
|
L
 25.9%
H
26
63.3
|
L
 161.6%
H
18.8
63.3
|
L
 230.9%
H
7.9
63.3
|
iRhythm Technologies Inc |
|
3,206.6
|
102.1
|
L
 3.3%
H
96.0
102.4
|
L
 1.7%
H
92.5
105.1
|
L
 -1.8%
H
92.5
110.4
|
L
 4.5%
H
87.0
128.5
|
L
 -11.1%
H
55.9
128.5
|
L
 -30.5%
H
55.9
164.7
|
L
 23.7%
H
41.7
286.2
|
L
H
22.2
286.2
|
Intuitive Surgical Inc |
|
176,844.3
|
493.6
|
L
 0.8%
H
480.3
496.6
|
L
 9.3%
H
425
529.2
|
L
 0.0%
H
425
529.2
|
L
 -9.8%
H
425
616
|
L
 25.8%
H
364.2
616
|
L
 76.9%
H
180.1
616
|
L
 193.9%
H
162.7
616
|
L
 737.6%
H
49.7
616
|
Jowell Global Ltd |
|
3.9
|
1.8
|
L
 -6.3%
H
1.8
2.0
|
L
 0.6%
H
1.7
2.1
|
L
 -22.5%
H
1.7
2.4
|
L
 -39.5%
H
1.7
3.2
|
L
 44.4%
H
1
3.7
|
L
 -94.6%
H
1
58.2
|
L
H
1
412.5
|
L
H
1
412.5
|
Kewaunee Scientific Corpor... |
|
94.9
|
33.2
|
L
 -3.8%
H
32.1
34.6
|
L
 -6.8%
H
32.1
38.5
|
L
 -29.6%
H
32.1
53.0
|
L
 -44.4%
H
32.1
71.3
|
L
 -4.6%
H
30.9
71.3
|
L
 129.2%
H
13.6
71.3
|
L
 315.5%
H
7.6
71.3
|
L
 91.0%
H
7.0
71.3
|
OrthoPediatrics corp |
|
525.4
|
21.2
|
L
 -1.1%
H
20.8
22.0
|
L
 -6.8%
H
20.8
23.6
|
L
 -17.7%
H
20.8
26.4
|
L
 -13.4%
H
20.8
27.6
|
L
 -33.0%
H
20.8
36.0
|
L
 -58.2%
H
20.8
60.8
|
L
 -50.7%
H
20.8
73.9
|
L
H
14
73.9
|
KORU Medical Systems Inc |
|
106.1
|
2.3
|
L
 0.9%
H
2.2
2.3
|
L
 0.9%
H
1.9
2.5
|
L
 -26.1%
H
1.9
3.3
|
L
 -41.9%
H
1.9
5.1
|
L
 3.1%
H
1.9
5.1
|
L
 -21.0%
H
1.8
5.1
|
L
 -74.8%
H
1.8
12.8
|
L
 505.3%
H
0.2
12.8
|
Standard BioTools Inc |
|
435.8
|
1.2
|
L
 4.6%
H
1.1
1.2
|
L
 7.5%
H
1.0
1.2
|
L
 0.9%
H
1.0
1.3
|
L
 -29.5%
H
1.0
2.1
|
L
 -60.5%
H
1.0
2.9
|
L
 -70.2%
H
0.9
4.0
|
L
 -46.5%
H
0.9
12.5
|
L
 -97.3%
H
0.9
45.6
|
LivaNova PLC |
|
1,845.8
|
34.0
|
L
 -0.5%
H
32.6
35.7
|
L
 -5.5%
H
32.5
37.5
|
L
 -13.1%
H
32.5
41.7
|
L
 -27.2%
H
32.5
52.1
|
L
 -37.2%
H
32.5
64.5
|
L
 -58.9%
H
32.5
88
|
L
 -33.2%
H
32.5
93.9
|
L
H
32.5
131.5
|
Lemaitre Vascular Inc |
|
1,868.3
|
82.8
|
L
 1.8%
H
80.0
83.2
|
L
 3.8%
H
71.4
87.5
|
L
 0.6%
H
71.4
87.5
|
L
 -11.5%
H
71.4
105.6
|
L
 26.1%
H
62.4
109.6
|
L
 81.5%
H
38.3
109.6
|
L
 201.5%
H
23.4
109.6
|
L
 888.3%
H
8.3
109.6
|
LENSAR Inc |
|
159.1
|
13.5
|
L
 0.7%
H
13.4
13.6
|
L
 -2.6%
H
13.1
14.0
|
L
 -5.5%
H
13.1
17.3
|
L
 63.5%
H
7.3
17.3
|
L
 321.6%
H
3.0
17.3
|
L
 77.5%
H
1.8
17.3
|
L
H
1.8
17.3
|
L
H
1.8
17.3
|
Lantheus Holdings Inc |
|
6,998.4
|
102
|
L
 3.5%
H
96
102.3
|
L
 12.2%
H
85
102.3
|
L
 -2.5%
H
85
105.7
|
L
 6.4%
H
77.7
111.3
|
L
 65.9%
H
59.6
126.9
|
L
 73.7%
H
47.5
126.9
|
L
 672.1%
H
10.5
126.9
|
L
H
1.8
126.9
|
Lucid Diagnostics Inc |
|
106.2
|
1.2
|
L
 -6.4%
H
1.1
1.3
|
L
 -18.8%
H
1.1
1.8
|
L
 -4.1%
H
1.1
1.8
|
L
 39.3%
H
0.8
1.8
|
L
 36.1%
H
0.6
1.8
|
L
 -58.2%
H
0.6
3.6
|
L
H
0.6
13.5
|
L
H
0.6
13.5
|
Pulmonx Corp |
|
211.3
|
5.3
|
L
 0.8%
H
5.1
5.5
|
L
 -22.3%
H
4.9
7.0
|
L
 -28.1%
H
4.9
8.1
|
L
 -22.3%
H
4.9
9.4
|
L
 -37.1%
H
4.9
10.0
|
L
 -79.9%
H
4.1
28.3
|
L
H
4.1
69.5
|
L
H
4.1
69.5
|
Masimo Corp |
|
8,316.0
|
153.9
|
L
 1.6%
H
149.5
156.5
|
L
 6.6%
H
133.7
169.0
|
L
 -7.6%
H
133.7
175.4
|
L
 -7.5%
H
133.7
194.9
|
L
 7.8%
H
101.6
194.9
|
L
 10.1%
H
75.2
198
|
L
 -17.0%
H
75.2
305.2
|
L
 340.1%
H
33.0
305.2
|
908 Devices Inc |
|
148.7
|
4.2
|
L
 11.1%
H
3.8
4.3
|
L
 10.5%
H
3.6
4.3
|
L
 21.7%
H
3.4
4.8
|
L
 86.3%
H
1.9
4.8
|
L
 -34.5%
H
1.8
7.5
|
L
 -78.2%
H
1.8
26
|
L
H
1.8
79.6
|
L
H
1.8
79.6
|
Mimedx Group Inc |
|
1,008.0
|
6.8
|
L
 -0.3%
H
6.5
7.0
|
L
 -3.1%
H
6.5
7.3
|
L
 -15.8%
H
6.5
8.2
|
L
 -20.9%
H
6.5
9.4
|
L
 3.5%
H
5.5
10.1
|
L
 51.0%
H
2.4
10.1
|
L
 71%
H
2.4
16.0
|
L
 -37.1%
H
1.0
18.3
|
Monogram Orthopaedics Inc |
|
88.9
|
2.5
|
L
 0.8%
H
2.5
2.7
|
L
 0.8%
H
2.4
2.7
|
L
 11.0%
H
2.2
4.2
|
L
 0.8%
H
2.1
4.2
|
L
 -38.1%
H
1.8
4.2
|
L
H
1.5
49.0
|
L
H
1.5
49.0
|
L
H
1.5
49.0
|
Meihua International Medic... |
|
10.2
|
0.3
|
L
H
0.3
0.3
|
L
 3.2%
H
0.3
0.3
|
L
 -3.0%
H
0.3
0.4
|
L
H
0.3
0.4
|
L
 -54.9%
H
0.3
1.5
|
L
 -96.4%
H
0.3
45.5
|
L
H
0.3
45.5
|
L
H
0.3
45.5
|
Mesa Laboratories, Inc. |
|
622.5
|
114.6
|
L
 4.3%
H
107.5
114.6
|
L
 6.1%
H
101.1
118.8
|
L
 -8.1%
H
97.2
130.1
|
L
 -14.8%
H
97.2
155.1
|
L
 9.4%
H
83.7
155.1
|
L
 -53.4%
H
82.9
255.6
|
L
 -49.2%
H
82.9
333.4
|
L
 57.9%
H
71.5
333.4
|
Merit Medical Systems, Inc. |
|
5,436.5
|
92.0
|
L
 0.6%
H
88.5
92.8
|
L
 -0.5%
H
85.5
96.3
|
L
 -6.5%
H
85.5
107.3
|
L
 -4.3%
H
85.5
111.5
|
L
 25.1%
H
70.7
111.5
|
L
 39.4%
H
50.5
111.5
|
L
 166.4%
H
33.0
111.5
|
L
 381.9%
H
15.5
111.5
|
Modular Medical Inc |
|
47.8
|
0.9
|
L
 4.7%
H
0.9
0.9
|
L
 1.1%
H
0.8
1.0
|
L
 6.0%
H
0.8
1.3
|
L
 -32.6%
H
0.7
1.4
|
L
 -42.6%
H
0.7
2.7
|
L
 -77.1%
H
0.7
5.4
|
L
 23.6%
H
0.7
19.5
|
L
 9.9%
H
0.6
19.5
|
Myriad Genetics, Inc. |
|
737.4
|
8
|
L
 0.6%
H
7.7
8.1
|
L
 -1.6%
H
7.4
8.6
|
L
 -22.0%
H
7.4
11.4
|
L
 -46.1%
H
7.4
15.5
|
L
 -61.0%
H
7.4
29.3
|
L
 -66.3%
H
7.4
29.3
|
L
 -47.5%
H
7.4
37.0
|
L
 -77.5%
H
7.4
50.4
|
MDxHealth SA - ADR |
|
-
|
1.6
|
L
 6.8%
H
1.5
1.6
|
L
 6.1%
H
1.4
1.6
|
L
 7.5%
H
1.4
1.7
|
L
 -20.7%
H
1.4
2.3
|
L
 -32.6%
H
1.4
3.5
|
L
 -78.4%
H
1.4
11.0
|
L
H
1.4
13.2
|
L
H
1.4
13.2
|
NanoVibronix Inc |
|
5.1
|
6.8
|
L
 5.0%
H
5.4
7.8
|
L
 186.9%
H
2.2
16.3
|
L
 1780.6%
H
0.2
16.3
|
L
 1201.9%
H
0.2
16.3
|
L
 757.0%
H
0.2
16.3
|
L
 -59.7%
H
0.2
16.8
|
L
 -83.7%
H
0.2
83.8
|
L
H
0.2
170
|
ENDRA Life Sciences Inc |
|
2.1
|
3.7
|
L
 -6.8%
H
3.4
4.0
|
L
 4.0%
H
3.4
6.2
|
L
 7.0%
H
3.3
6.2
|
L
 -38.5%
H
3.2
6.3
|
L
 -80.1%
H
0.0
19
|
L
 -98.8%
H
0.0
380
|
L
 -99.5%
H
0.0
3100
|
L
H
0.0
5880
|
Neogen Corp. |
|
1,211.1
|
5.6
|
L
 -0.9%
H
5.3
5.8
|
L
 -28.5%
H
3.9
8.3
|
L
 -43.6%
H
3.9
10.0
|
L
 -54.9%
H
3.9
13.0
|
L
 -57.1%
H
3.9
18.6
|
L
 -82.0%
H
3.9
31.8
|
L
 -82.4%
H
3.9
48.9
|
L
 -68.2%
H
3.9
48.9
|
Nephros Inc |
|
20.1
|
1.9
|
L
H
1.9
1.9
|
L
 -6.9%
H
1.7
2.1
|
L
 17.3%
H
1.5
2.2
|
L
 25.8%
H
1.4
2.2
|
L
 -5%
H
1.4
2.6
|
L
 -59.0%
H
0.9
4.7
|
L
 -75.9%
H
0.9
11.7
|
L
 -61.6%
H
0.9
11.7
|
NeuroOne Medical Technolog... |
|
14.8
|
0.5
|
L
 9.3%
H
0.4
0.5
|
L
 -2.1%
H
0.4
0.5
|
L
 -47.8%
H
0.4
1.1
|
L
 -58.4%
H
0.4
1.4
|
L
 -61.2%
H
0.4
1.4
|
L
 -54.8%
H
0.4
3.0
|
L
 -91.9%
H
0.4
13.5
|
L
H
0.4
30
|
Nano X Imaging Ltd |
|
293.9
|
4.6
|
L
 5.0%
H
4.3
4.6
|
L
 4.8%
H
3.8
4.7
|
L
 -15.3%
H
3.8
6.2
|
L
 -42.9%
H
3.8
9.2
|
L
 -56.1%
H
3.8
11
|
L
 -59.0%
H
3.8
22.7
|
L
H
3.8
94.8
|
L
H
3.8
94.8
|
NeuroPace Inc |
|
339.3
|
10.4
|
L
 -2.1%
H
9.9
10.8
|
L
 -14.8%
H
9.9
12.7
|
L
 0.6%
H
9.9
13.6
|
L
 -12.7%
H
9.6
15.1
|
L
 -28.1%
H
5.5
15.1
|
L
 32.1%
H
1.2
18.2
|
L
H
1.2
27.4
|
L
H
1.2
27.4
|
InspireMD Inc |
|
76.0
|
2.6
|
L
 -3.8%
H
2.5
2.6
|
L
 -3.0%
H
2.2
2.7
|
L
 -8.2%
H
2.2
3.3
|
L
 -7.3%
H
2.2
3.8
|
L
 9.4%
H
1.8
3.8
|
L
 -16.9%
H
0.8
3.9
|
L
 -74.3%
H
0.8
22.2
|
L
 -100.0%
H
0.8
2779218.8
|
Nortech Systems Inc. |
|
22.0
|
8.0
|
L
 1.8%
H
7.6
8.2
|
L
 -11.6%
H
7.3
8.9
|
L
 -17.6%
H
7.3
10.2
|
L
 -20.2%
H
7.3
11.1
|
L
 -51.1%
H
7.3
19.2
|
L
 -21.7%
H
7.3
19.6
|
L
 105.2%
H
2.9
19.6
|
L
 64.1%
H
1.7
19.6
|
Natera Inc |
|
20,013.0
|
148.0
|
L
 3.3%
H
141.2
149.0
|
L
 10.6%
H
125.4
152.0
|
L
 5.7%
H
125.4
155.6
|
L
 -15.4%
H
125.4
183
|
L
 53.1%
H
83.1
183
|
L
 263.0%
H
27.4
183
|
L
 360.2%
H
26.1
183
|
L
H
6.5
183
|
Nutriband Inc |
|
52.4
|
4.7
|
L
H
4.6
4.8
|
L
 -12.6%
H
4.5
5.4
|
L
 -22.6%
H
4.5
6.9
|
L
 14.3%
H
3.9
11.8
|
L
 9.0%
H
3.2
11.8
|
L
 4.4%
H
1.5
11.8
|
L
 -47.6%
H
0.9
27.4
|
L
H
0.9
43.5
|
Neurometrix Inc. |
|
9.1
|
4.4
|
L
H
4.4
4.4
|
L
H
4.3
4.5
|
L
 1.4%
H
4.3
4.7
|
L
 11.1%
H
3.9
4.7
|
L
 14.6%
H
2.7
4.7
|
L
 6.0%
H
0.5
5.9
|
L
 231.6%
H
0.5
38.8
|
L
 -99.0%
H
0.5
499.2
|
Nuwellis Inc |
|
4.1
|
0.9
|
L
 -1.1%
H
0.9
1.0
|
L
 12.1%
H
0.8
1.0
|
L
 -23.1%
H
0.8
1.2
|
L
 -8.8%
H
0.8
1.7
|
L
 -93.2%
H
0.1
14
|
L
 -100.0%
H
0.1
6475
|
L
 -100.0%
H
0.1
131250
|
L
 -100.0%
H
0.1
4374720000
|
NovoCure Ltd |
|
1,813.6
|
16.5
|
L
 2.6%
H
15.8
16.5
|
L
 0.1%
H
14.8
17.4
|
L
 -22.6%
H
14.8
21.6
|
L
 -39.9%
H
14.8
28.1
|
L
 16.9%
H
11.7
34.1
|
L
 -79.9%
H
10.9
120.0
|
L
 -76.4%
H
10.9
232.8
|
L
H
6.0
232.8
|
enVVeno Medical Corporation |
|
38.4
|
2.2
|
L
 3.3%
H
2.1
2.2
|
L
 -4.4%
H
2.0
2.4
|
L
 -23.4%
H
2.0
3.1
|
L
 -32.4%
H
2.0
3.9
|
L
 -56.8%
H
2.0
6.5
|
L
 -59.4%
H
2.0
7.9
|
L
 -71.7%
H
2.0
20.3
|
L
H
2.0
141
|
Nexalin Technology Inc |
|
24.6
|
1.9
|
L
 5.7%
H
1.7
1.9
|
L
 9.5%
H
1.5
1.9
|
L
 -14.4%
H
1.5
2.6
|
L
 -30.5%
H
1.5
3.9
|
L
 -24.8%
H
0.5
4.5
|
L
H
0.3
4.5
|
L
H
0.3
4.5
|
L
H
0.3
4.5
|
Nyxoah SA |
|
230.2
|
6.2
|
L
 2.3%
H
6.0
6.3
|
L
 1.2%
H
5.6
7
|
L
 -38.2%
H
5.6
11.9
|
L
 -33.5%
H
5.6
11.9
|
L
 -36.7%
H
5.6
12.2
|
L
 -67.5%
H
4
20
|
L
H
4
37
|
L
H
4
37
|
Nanobiotix - ADR |
|
157.9
|
3.3
|
L
 4.7%
H
3.2
3.3
|
L
 2.2%
H
3.0
3.4
|
L
 8.1%
H
3.0
4.0
|
L
 17.7%
H
2.8
4.3
|
L
 -46.1%
H
2.8
7.5
|
L
 -53.3%
H
1.8
11
|
L
H
1.8
21.6
|
L
H
1.8
21.6
|
Orchestra BioMed Holdings Inc |
|
114.2
|
3.0
|
L
 14.6%
H
2.6
3.0
|
L
 8.0%
H
2.5
3.2
|
L
 -25.5%
H
2.5
4.8
|
L
 -45.5%
H
2.5
6.2
|
L
 -41.0%
H
2.5
8.9
|
L
 -70.0%
H
2.5
23.4
|
L
H
2.5
23.4
|
L
H
2.5
23.4
|
Orthofix Medical Inc |
|
533.4
|
13.7
|
L
 -1.8%
H
13.2
14.0
|
L
 -6.2%
H
13.2
15.2
|
L
 -20.1%
H
13.2
17.3
|
L
 -19.6%
H
13.2
20.5
|
L
 -2.0%
H
12.1
20.7
|
L
 -57.0%
H
9.6
35.3
|
L
 -55.4%
H
9.6
48.5
|
L
 -63.4%
H
9.6
74.4
|
Outset Medical Inc |
|
179.8
|
10.2
|
L
 5.8%
H
9.1
10.2
|
L
 -6.7%
H
8.4
10.7
|
L
 16.8%
H
0.5
12.6
|
L
 -26.4%
H
0.5
16.2
|
L
 -70.2%
H
0.5
78.3
|
L
 -98.5%
H
0.5
699.6
|
L
H
0.5
1004.4
|
L
H
0.5
1004.4
|
Organogenesis Holdings Inc... |
|
540.3
|
4.3
|
L
 13.6%
H
3.6
4.3
|
L
 10.1%
H
3.5
4.3
|
L
 -19.6%
H
3.5
5.6
|
L
 41.5%
H
2.9
6.7
|
L
 42%
H
2.2
6.7
|
L
 -44.7%
H
1.8
8.2
|
L
 28.7%
H
1.8
24.3
|
L
H
1.8
310.9
|
Orasure Technologies Inc. |
|
227.0
|
2.9
|
L
 -0.3%
H
2.9
3.0
|
L
 -5.8%
H
2.9
3.2
|
L
 -13.3%
H
2.9
4.2
|
L
 -19.1%
H
2.7
4.2
|
L
 -49.2%
H
2.7
5.7
|
L
 -57.1%
H
2.6
8.5
|
L
 -72.9%
H
2.6
19.8
|
L
 -56.9%
H
2.6
23.0
|
Pacific Biosciences of Cal... |
|
405.1
|
1.4
|
L
 -1.5%
H
1.3
1.4
|
L
 10.6%
H
1.2
1.5
|
L
 3.8%
H
1.1
1.5
|
L
 -35.2%
H
1.1
2.1
|
L
 -59.8%
H
1.1
3.4
|
L
 -83.4%
H
1.1
14.6
|
L
 -53.1%
H
1.1
53.7
|
L
 -77.1%
H
1.1
53.7
|
PAVmed Inc |
|
11.2
|
0.7
|
L
H
0.6
0.7
|
L
 13.3%
H
0.6
0.7
|
L
 7.9%
H
0.6
0.8
|
L
 11.5%
H
0.6
0.9
|
L
 -66%
H
0.6
2.4
|
L
 -34.6%
H
0.2
4.4
|
L
 -64.4%
H
0.2
9.7
|
L
H
0.2
15.2
|
Patterson Companies Inc. |
|
2,734.7
|
30.9
|
L
 -0.1%
H
30.8
31.0
|
L
 -0.1%
H
30.6
31.3
|
L
 -0.8%
H
30.6
31.3
|
L
 0.3%
H
30.6
31.3
|
L
 20.1%
H
19.5
31.8
|
L
 -8.1%
H
19.5
35.3
|
L
 102.8%
H
14.3
37.4
|
L
 -36.0%
H
12.9
53.1
|
Pro-Dex Inc. (co) |
|
206.2
|
63.2
|
L
 3.5%
H
59.9
65.9
|
L
 24.2%
H
46.8
65.9
|
L
 32.3%
H
44.7
65.9
|
L
 34.6%
H
30.8
65.9
|
L
 243.6%
H
16.8
65.9
|
L
 329.0%
H
12.4
65.9
|
L
 286.7%
H
12.4
65.9
|
L
 2954.6%
H
2.0
65.9
|
PetVivo Holdings Inc |
|
11.8
|
0.5
|
L
 -7.4%
H
0.5
0.5
|
L
 -18.0%
H
0.5
0.6
|
L
 -5.7%
H
0.5
0.6
|
L
 -46.2%
H
0.5
1.0
|
L
 -10.7%
H
0.3
1.0
|
L
 -72.8%
H
0.3
3.6
|
L
 -64.0%
H
0.3
17
|
L
 -97.2%
H
0.2
30.4
|
Pulse Biosciences Inc |
|
1,079.1
|
16.0
|
L
 3.1%
H
15.5
16.2
|
L
 6.4%
H
13.8
16.2
|
L
 -6.4%
H
13.8
17.9
|
L
 -13.1%
H
13.8
25
|
L
 120.9%
H
6.6
25
|
L
 341.9%
H
1.2
25
|
L
 129.8%
H
1.2
45.8
|
L
H
1.2
45.8
|
Predictive Oncology Inc |
|
8.9
|
1
|
L
 3.1%
H
1.0
1.0
|
L
 -25.4%
H
0.9
1.3
|
L
 -6.5%
H
0.9
2.6
|
L
 -26.5%
H
0.9
2.6
|
L
 -43.8%
H
0.6
3.1
|
L
 -93.5%
H
0.6
16.2
|
L
 -96.4%
H
0.6
46
|
L
 -100.0%
H
0.6
35750
|
Precision Optics Corp., Inc. |
|
29.9
|
3.9
|
L
 0.5%
H
3.9
4
|
L
 -6.7%
H
3.8
4.5
|
L
 -13.3%
H
3.8
4.8
|
L
 -18.3%
H
3.8
5.3
|
L
 -26.9%
H
3.5
6.9
|
L
H
3.5
7.9
|
L
H
3.5
7.9
|
L
H
3.5
7.9
|
Insulet Corporation |
|
17,836.7
|
254.0
|
L
 1%
H
246.2
255.3
|
L
 3.6%
H
236.7
266.1
|
L
 3.5%
H
236.7
276.1
|
L
 -6.7%
H
230.1
289.5
|
L
 41.4%
H
160.2
289.5
|
L
 -1.6%
H
125.8
335.9
|
L
 38.8%
H
125.8
335.9
|
L
 733.0%
H
23.9
335.9
|
Procept BioRobotics Corp |
|
2,854.4
|
52.1
|
L
 2.6%
H
49.0
52.5
|
L
 1.6%
H
47.0
55.0
|
L
 -12.6%
H
47.0
64.4
|
L
 -40.1%
H
47.0
85
|
L
 -2.3%
H
47.0
103.8
|
L
 52.5%
H
24.8
103.8
|
L
H
15.4
103.8
|
L
H
15.4
103.8
|
Prenetics Global Limited -... |
|
44.0
|
3.6
|
L
 1.1%
H
3.5
3.7
|
L
 -4.5%
H
3.1
4
|
L
 -18.2%
H
3.1
4.5
|
L
 -33.7%
H
3.1
6
|
L
 -5.8%
H
2.9
7.8
|
L
 -96.9%
H
2.9
131.3
|
L
H
2.9
131.3
|
L
H
2.9
131.3
|
Profound Medical Corp |
|
140.9
|
4.7
|
L
 4.7%
H
4.5
4.7
|
L
 -6.2%
H
3.9
5.2
|
L
 -31.2%
H
3.9
7.3
|
L
 -38.0%
H
3.9
7.8
|
L
 -43.5%
H
3.9
11.4
|
L
 -45.1%
H
3.1
15.5
|
L
 -59.6%
H
3.1
29.0
|
L
H
0.0
29.0
|
QuidelOrtho Corporation |
|
1,815.2
|
26.9
|
L
 1.9%
H
25.9
27.2
|
L
 -4.3%
H
25.1
29.9
|
L
 -27.8%
H
25.1
38.4
|
L
 -41.2%
H
25.1
46.3
|
L
 -37.4%
H
25.1
49.5
|
L
 -76.2%
H
25.1
116.9
|
L
 -72.0%
H
25.1
306.7
|
L
 5.4%
H
13.2
306.7
|
Quanterix Corp |
|
201.7
|
5.2
|
L
 8.1%
H
4.7
5.2
|
L
 -12.5%
H
4.7
5.7
|
L
 -31.6%
H
4.7
7.7
|
L
 -44.8%
H
4.7
10.4
|
L
 -73.9%
H
4.7
19.7
|
L
 -81.9%
H
4.7
30.4
|
L
 -75.3%
H
4.7
92.6
|
L
H
4.7
92.6
|
AVITA Medical Inc |
|
227.2
|
8.6
|
L
 -0.1%
H
8.2
8.7
|
L
 14.9%
H
7.0
8.9
|
L
 3.0%
H
6.9
9.8
|
L
 -5.7%
H
6.9
11.3
|
L
 -16.7%
H
6.9
14.2
|
L
 6.4%
H
4.4
21.7
|
L
 -74.3%
H
4.4
35.0
|
L
 40.2%
H
3.8
55.4
|
Rockwell Medical Inc |
|
36.1
|
1.1
|
L
 -0.9%
H
1.0
1.1
|
L
 6%
H
0.9
1.1
|
L
 -30.3%
H
0.9
1.9
|
L
 -49.0%
H
0.9
2.3
|
L
 -34.6%
H
0.9
5.2
|
L
 -74.6%
H
0.8
6.2
|
L
 -95.7%
H
0.8
28.8
|
L
 -99.1%
H
0.8
207.9
|
ReShape Lifesciences Inc. |
|
5.2
|
0.5
|
L
 -19.3%
H
0.5
0.6
|
L
H
0.3
0.7
|
L
 -33.3%
H
0.3
3.1
|
L
 -90.0%
H
0.3
6.6
|
L
 -95.2%
H
0.3
29
|
L
 -100.0%
H
0.3
3538
|
L
 -100.0%
H
0.3
93699
|
L
H
0.3
1381560
|
Sanmina Corp |
|
4,126.0
|
76.0
|
L
 1.8%
H
73.0
76.4
|
L
 12.9%
H
63.7
79.7
|
L
 1.4%
H
63.7
81.3
|
L
 -1.9%
H
63.7
91.1
|
L
 28.3%
H
57.5
91.1
|
L
 98.8%
H
36.4
91.1
|
L
 180.9%
H
23.8
91.1
|
L
 205.9%
H
16.3
91.1
|
Sight Sciences Inc |
|
122.2
|
2.4
|
L
 5.3%
H
2.2
2.4
|
L
 3.5%
H
2.0
2.5
|
L
 -14.7%
H
2.0
3.1
|
L
 -26.8%
H
2.0
3.3
|
L
 -61.0%
H
2.0
8.5
|
L
 -75.5%
H
1.0
15.3
|
L
H
1.0
42.6
|
L
H
1.0
42.6
|
Sotera Health Co |
|
2,983.3
|
10.5
|
L
 -0.9%
H
10.1
10.7
|
L
 1.6%
H
9.5
11.4
|
L
 -7.6%
H
9.5
13.0
|
L
 -19.8%
H
9.5
14
|
L
 -8.0%
H
9.5
17.1
|
L
 -51.8%
H
5.8
24.9
|
L
H
5.8
30.4
|
L
H
5.8
30.4
|
SI-BONE Inc |
|
567.6
|
13.4
|
L
 0.9%
H
12.9
13.8
|
L
 -0.7%
H
12.5
14.2
|
L
 -13.1%
H
12.5
15.6
|
L
 -2.6%
H
12.5
19.2
|
L
 -14.8%
H
11.7
19.2
|
L
 -37.6%
H
11.1
29.5
|
L
 -1.8%
H
11.1
37.2
|
L
H
7.2
37.2
|
SINTX Technologies Inc |
|
4.8
|
1.9
|
L
 -1.6%
H
1.9
1.9
|
L
 -7.8%
H
1.8
2.2
|
L
 -41.9%
H
1.8
3.6
|
L
 -44.0%
H
1.8
7.4
|
L
 -61.9%
H
0.1
45.6
|
L
 -100.0%
H
0.1
14160
|
L
 -100.0%
H
0.1
68800
|
L
 -100.0%
H
0.1
90612000
|
Beauty Health Company (The... |
|
131.5
|
1.1
|
L
 5%
H
1.0
1.1
|
L
 -12.5%
H
1.0
1.2
|
L
 -22.8%
H
1.0
1.6
|
L
 -32.3%
H
1.0
1.8
|
L
 -72.4%
H
0.9
3.8
|
L
 -93.1%
H
0.9
16.2
|
L
H
0.9
30.2
|
L
H
0.9
30.2
|
Semler Scientific Inc |
|
324.0
|
33.8
|
L
 3.5%
H
31.5
33.9
|
L
 -0.3%
H
30.2
36.7
|
L
 2.9%
H
30.2
43.5
|
L
 -34.3%
H
30.2
66.5
|
L
 21.4%
H
20.9
81.6
|
L
 -26.8%
H
19.1
81.6
|
L
 -19.6%
H
19.1
153.2
|
L
 788.4%
H
1.1
153.2
|
Sanara MedTech Inc |
|
258.6
|
29.1
|
L
 0.7%
H
27.7
29.5
|
L
 4.5%
H
25.9
29.7
|
L
 -9.1%
H
25.9
35.7
|
L
 -9.9%
H
25.9
38.7
|
L
 -11.8%
H
25.9
39.1
|
L
 3.9%
H
17.4
50.2
|
L
 187.6%
H
7.9
53.9
|
L
 222.8%
H
2
75
|
Surmodics, Inc. |
|
407.3
|
28.5
|
L
 4.6%
H
27.5
28.5
|
L
 -2.8%
H
26.5
29.2
|
L
 3.6%
H
26.5
31.2
|
L
 -25.9%
H
26.5
38.6
|
L
 2.9%
H
25.2
42.4
|
L
 -32.2%
H
16
45.9
|
L
 -17.7%
H
16
62.3
|
L
 9.8%
H
16
82.4
|
Sensus Healthcare Inc |
|
76.0
|
4.6
|
L
 0.7%
H
4.5
4.7
|
L
 3.4%
H
4.1
4.7
|
L
 3.6%
H
4.1
5.2
|
L
 -29.5%
H
4.1
9.1
|
L
 46.8%
H
3.1
9.3
|
L
 -47.0%
H
1.8
15.3
|
L
 78.7%
H
1.8
15.3
|
L
H
1.8
15.3
|
STRATA Skin Sciences Inc |
|
10.6
|
2.5
|
L
 0.8%
H
2.5
2.6
|
L
 -2.3%
H
2.5
2.7
|
L
 -2.7%
H
2.5
2.9
|
L
 -14.2%
H
2.5
3.1
|
L
 -51.9%
H
2.5
41
|
L
 -81.8%
H
2.5
41
|
L
 -71.9%
H
2.5
41
|
L
 -97.9%
H
2.5
117.5
|
Staar Surgical Co. |
|
828.2
|
16.8
|
L
 7.8%
H
15.4
17.2
|
L
 5.5%
H
14.7
17.3
|
L
 -8.5%
H
14.7
18.6
|
L
 -27%
H
13.5
25.4
|
L
 -67.5%
H
13.5
51.3
|
L
 -74.5%
H
13.5
112.3
|
L
 -50.2%
H
13.5
163.1
|
L
 100.8%
H
5.0
163.1
|
Neuronetics Inc |
|
249.4
|
3.8
|
L
 0.5%
H
3.6
4.1
|
L
 7.4%
H
3.2
4.2
|
L
 -16.5%
H
3.2
5.3
|
L
 121.6%
H
1.8
5.9
|
L
 -12.3%
H
0.5
5.9
|
L
 29.4%
H
0.5
7.0
|
L
 93.4%
H
0.5
22.4
|
L
H
0.5
39.4
|
Star Equity Holdings Inc |
|
6.4
|
2
|
L
 2.0%
H
2.0
2.1
|
L
 -8.7%
H
1.9
2.2
|
L
 -15.3%
H
1.9
2.9
|
L
 -9.9%
H
1.9
2.9
|
L
 -56.0%
H
1.9
5.4
|
L
 -63.6%
H
1.9
8.0
|
L
 -87.3%
H
1.9
27
|
L
 -99.2%
H
1.9
346
|
Sharps Technology Inc |
|
0.3
|
0.0
|
L
H
0.0
0.0
|
L
 -33.3%
H
0.0
0.0
|
L
 -94.4%
H
0.0
0.4
|
L
 -99.0%
H
0.0
2.1
|
L
 -94.4%
H
0.0
4.2
|
L
H
0.0
4.2
|
L
H
0.0
4.2
|
L
H
0.0
4.2
|
Tactile Systems Technology... |
|
314.0
|
13.3
|
L
 -1.0%
H
13.1
13.7
|
L
 0.6%
H
12.3
14.0
|
L
 -4.7%
H
12.3
14.2
|
L
 -23.0%
H
12.3
18.5
|
L
 -11.8%
H
11.1
21.1
|
L
 -28.1%
H
6.3
26.1
|
L
 -72.7%
H
6.3
64.5
|
L
H
6.3
76.6
|
TELA Bio Inc |
|
38.8
|
1.0
|
L
 4.3%
H
0.9
1.0
|
L
 -9.3%
H
0.9
1.1
|
L
 -57.4%
H
0.9
2.5
|
L
 -65.1%
H
0.9
3.0
|
L
 -80.2%
H
0.9
6.5
|
L
 -90.9%
H
0.9
13.2
|
L
 -88.4%
H
0.9
23.5
|
L
H
0.9
23.5
|
Tivic Health Systems Inc |
|
2.7
|
4.4
|
L
 -1.8%
H
4.3
4.7
|
L
 -2.2%
H
3.3
5.7
|
L
 35.3%
H
2.4
5.8
|
L
 -16.8%
H
2.4
15.6
|
L
 -78.0%
H
2.4
31.5
|
L
 -99.8%
H
2.4
4879
|
L
H
2.4
11050
|
L
H
2.4
11050
|
Treace Medical Concepts Inc |
|
420.5
|
6.7
|
L
 -3.6%
H
6.5
7.1
|
L
 -13.0%
H
6.5
8.1
|
L
 -18.7%
H
6.5
8.9
|
L
 -7.7%
H
6.5
10.8
|
L
 -46.6%
H
3.9
12.6
|
L
 -64.2%
H
3.9
28.0
|
L
H
3.9
37.2
|
L
H
3.9
37.2
|
Transmedics Group Inc |
|
2,725.9
|
80.6
|
L
 5.5%
H
75.5
81.3
|
L
 19.1%
H
62.2
81.3
|
L
 19.1%
H
62.2
81.3
|
L
 17.1%
H
55
81.3
|
L
 -14.2%
H
55
177.4
|
L
 215.4%
H
20.4
177.4
|
L
 435.4%
H
10
177.4
|
L
H
10
177.4
|
Tandem Diabetes Care Inc |
|
1,135.6
|
17.1
|
L
 0.1%
H
16.6
17.3
|
L
 1.1%
H
15.8
18.2
|
L
 -4.6%
H
15.8
21.2
|
L
 -52.6%
H
15.8
37.9
|
L
 -49.6%
H
15.8
53.7
|
L
 -85.6%
H
13.8
122.7
|
L
 -74.9%
H
13.8
155.9
|
L
 -86.8%
H
2.1
155.9
|
T2 Biosystems Inc |
|
3.1
|
0.1
|
L
 -8.3%
H
0.1
0.1
|
L
 -8.3%
H
0.1
0.1
|
L
 -15.4%
H
0.1
0.1
|
L
 -65.6%
H
0.1
0.3
|
L
 -96.5%
H
0.1
6.8
|
L
 -100.0%
H
0.1
2775
|
L
 -100.0%
H
0.1
18950
|
L
 -100.0%
H
0.1
99490
|
Trinity Biotech Plc - ADR |
|
11.1
|
0.6
|
L
 3.6%
H
0.5
0.6
|
L
 7.4%
H
0.5
0.6
|
L
 -21.6%
H
0.5
0.8
|
L
 -31.0%
H
0.5
1.5
|
L
 -68.3%
H
0.5
3.6
|
L
 -49.1%
H
0.4
3.6
|
L
 -37.0%
H
0.4
6.8
|
L
 -96.7%
H
0.4
19.0
|
Utah Medical Products, Inc. |
|
174.1
|
53.0
|
L
 0.3%
H
52.5
53.4
|
L
 -3.3%
H
52.5
57.0
|
L
 -8.8%
H
52.5
58.8
|
L
 -12.5%
H
52.5
65.6
|
L
 -24.4%
H
52.5
77.3
|
L
 -38.7%
H
52.5
109.5
|
L
 -40.2%
H
52.5
133.9
|
L
 -9.8%
H
50
133.9
|
Vivani Medical Inc |
|
60.4
|
1.0
|
L
 1.0%
H
1.0
1.0
|
L
 6.3%
H
0.9
1.1
|
L
 -2.9%
H
0.9
1.2
|
L
 -15.7%
H
0.9
1.2
|
L
 -50.2%
H
0.9
2.1
|
L
 -73.4%
H
0.8
8.1
|
L
 -67.9%
H
0.8
60
|
L
 -99.7%
H
0.8
420
|
Veracyte Inc |
|
2,478.6
|
31.8
|
L
 5.1%
H
29.5
31.8
|
L
 9.8%
H
27.1
33.2
|
L
 2.3%
H
27.1
34.2
|
L
 -23.5%
H
27.1
47.3
|
L
 53.4%
H
18.6
47.3
|
L
 25.6%
H
14.9
47.3
|
L
 41.6%
H
14.9
86.0
|
L
 289.7%
H
4.2
86.0
|
Venus Concept Inc |
|
2.8
|
4.3
|
L
 6.2%
H
4.2
4.6
|
L
 82.6%
H
2.3
14.5
|
L
 56.7%
H
2.2
14.5
|
L
 1005.1%
H
0.3
14.5
|
L
 515.7%
H
0.3
14.5
|
L
 -78.7%
H
0.3
20.9
|
L
 -92.8%
H
0.3
75
|
L
H
0.3
2688.8
|
Varex Imaging Corp |
|
323.3
|
7.8
|
L
 1.3%
H
7.4
7.9
|
L
 -5.3%
H
7.3
8.7
|
L
 -38.8%
H
7.3
13.1
|
L
 -41.4%
H
7.3
15.5
|
L
 -56.2%
H
7.3
17.8
|
L
 -62.2%
H
7.3
23.9
|
L
 -68.0%
H
7.3
32.7
|
L
H
7.3
43.8
|
Vivos Therapeutics Inc |
|
13.7
|
2.3
|
L
 1.8%
H
2.2
2.4
|
L
 -8.6%
H
2
2.6
|
L
 -30.7%
H
2
3.8
|
L
 -54.1%
H
2
6.3
|
L
 -15.0%
H
1.9
6.3
|
L
 -95.3%
H
1.9
74.1
|
L
H
1.9
360.3
|
L
H
1.9
360.3
|
Wrap Technologies Inc |
|
74.7
|
1.5
|
L
 4.2%
H
1.4
1.5
|
L
 0.7%
H
1.3
1.6
|
L
 -24.1%
H
1.3
2.4
|
L
 -28.2%
H
1.3
2.6
|
L
 -27.8%
H
1.2
2.6
|
L
 -45.4%
H
1.0
7.0
|
L
 -66.1%
H
1.0
14.4
|
L
H
1.0
14.4
|
Beyond Air Inc |
|
21.2
|
0.2
|
L
 4.4%
H
0.2
0.2
|
L
H
0.2
0.3
|
L
 -4%
H
0.2
0.3
|
L
 -38.5%
H
0.2
0.5
|
L
 -84%
H
0.2
1.6
|
L
 -96.2%
H
0.2
11.8
|
L
 -97.3%
H
0.2
16.4
|
L
H
0.2
45
|
DENTSPLY Sirona Inc |
|
2,455.6
|
12.8
|
L
 1.0%
H
12.2
12.9
|
L
 -6.0%
H
12.2
13.9
|
L
 -19.7%
H
12.2
16.1
|
L
 -29.5%
H
12.2
20.6
|
L
 -60.1%
H
12.2
31.8
|
L
 -73.7%
H
12.2
49.4
|
L
 -69.5%
H
12.2
69.5
|
L
 -75.3%
H
12.2
69.5
|
X.T.L. Biopharmaceuticals ... |
|
9.9
|
1.1
|
L
 -3.5%
H
1.1
1.2
|
L
 -11.8%
H
1.1
1.2
|
L
 -15.8%
H
0.9
1.4
|
L
 -39.8%
H
0.9
2.0
|
L
 -59.4%
H
0.9
3.2
|
L
 -50.9%
H
0.8
5.0
|
L
 7.7%
H
0.8
6.7
|
L
 -90.5%
H
0.6
11.9
|
111 Inc - ADR |
|
58.7
|
6.9
|
L
 11.4%
H
6.3
6.9
|
L
 -6.6%
H
6.1
7.2
|
L
 -15.4%
H
6.1
11.3
|
L
 1298.0%
H
0.4
11.3
|
L
 540.2%
H
0.4
11.3
|
L
 211.4%
H
0.4
11.3
|
L
 -8.7%
H
0.4
45.9
|
L
H
0.4
45.9
|
ZimVie Inc |
|
254.8
|
9.2
|
L
 0.9%
H
8.9
9.3
|
L
 -3.4%
H
8.6
10.2
|
L
 -26.9%
H
8.6
12.9
|
L
 -32.2%
H
8.6
15.3
|
L
 -46.0%
H
8.6
22.3
|
L
 -61.8%
H
5.1
28.9
|
L
H
5.1
50.4
|
L
H
5.1
50.4
|
Jin Medical International Ltd |
|
114.3
|
0.7
|
L
 17.7%
H
0.7
0.8
|
L
 17.7%
H
0.6
0.8
|
L
 -12.1%
H
0.6
1.0
|
L
 -9.9%
H
0.6
1.1
|
L
 -77.5%
H
0.6
4.7
|
L
H
0.6
509.9
|
L
H
0.6
509.9
|
L
H
0.6
509.9
|
Zynex Inc |
|
65.9
|
2.2
|
L
 1.4%
H
2.0
2.2
|
L
 0.9%
H
1.9
2.5
|
L
 -68.9%
H
1.9
5.1
|
L
 -72.2%
H
1.9
8.5
|
L
 -82.0%
H
1.9
12.3
|
L
 -66.6%
H
1.9
17.3
|
L
 -81.6%
H
1.9
27.0
|
L
 1457.1%
H
0.1
27.0
|
HeartBeam Inc |
|
56.7
|
1.7
|
L
 3.1%
H
1.6
1.7
|
L
 -0.6%
H
1.5
1.8
|
L
 -19.6%
H
1.5
2.2
|
L
 -20.4%
H
1.5
2.5
|
L
 -16.4%
H
1.5
3.5
|
L
 6.3%
H
1.4
3.5
|
L
 6.3%
H
1.4
3.5
|
L
 6.3%
H
1.4
3.5
|
Cencora Inc. |
|
55,078.3
|
284.3
|
L
 1.9%
H
277.5
286.5
|
L
 2.1%
H
267.4
286.5
|
L
 9.1%
H
251.9
296.7
|
L
 20.4%
H
233.6
296.7
|
L
 20.7%
H
214.8
296.7
|
L
 74.8%
H
135.1
296.7
|
L
 223.8%
H
81.5
296.7
|
L
 146.5%
H
68.4
296.7
|
Incannex Healthcare Limite... |
|
17.4
|
0.6
|
L
 10.5%
H
0.6
0.6
|
L
 21.2%
H
0.5
1.4
|
L
 -13.7%
H
0.5
1.4
|
L
 -66.0%
H
0.5
2.3
|
L
 -79.8%
H
0.5
3.6
|
L
 -88.5%
H
0.5
5.3
|
L
 -88.5%
H
0.5
5.3
|
L
 -88.5%
H
0.5
5.3
|
Rewalk Robotics Ltd. |
|
15.2
|
1.4
|
L
 2.9%
H
1.3
1.4
|
L
 -2.7%
H
1.2
1.5
|
L
 -1.4%
H
1.2
3.0
|
L
 -24.7%
H
1.2
3.0
|
L
 -72.1%
H
1.2
6
|
L
 -82.2%
H
1.2
9.1
|
L
 -62.2%
H
1.2
42
|
L
 -99.9%
H
1.2
3045
|
Xylo Technologies Ltd. - ADR |
|
3.7
|
5.1
|
L
 -1.9%
H
4.9
5.8
|
L
 5.2%
H
4.7
5.9
|
L
 -3.4%
H
4.5
5.9
|
L
 24.7%
H
3.6
5.9
|
L
 -20.3%
H
2.7
17.8
|
L
 -99.2%
H
2.7
714
|
L
 -99.2%
H
2.7
3090
|
L
H
2.7
4963200
|
Work Medical Technology Gr... |
|
5.4
|
0.4
|
L
 -5.1%
H
0.4
0.4
|
L
 -24.5%
H
0.4
0.5
|
L
 -40.3%
H
0.4
0.7
|
L
 -91.4%
H
0.4
6
|
L
H
0.4
8.5
|
L
H
0.4
8.5
|
L
H
0.4
8.5
|
L
H
0.4
8.5
|
Pheton Holdings Ltd. - Ord... |
|
41.8
|
2.9
|
L
 -3.9%
H
2.9
3.3
|
L
 -12.8%
H
2.9
4.0
|
L
 -11.2%
H
2.9
4.9
|
L
 -25.6%
H
1.3
5
|
L
H
1.3
6.5
|
L
H
1.3
6.5
|
L
H
1.3
6.5
|
L
H
1.3
6.5
|
Ceribell Inc. |
|
538.0
|
15
|
L
 34.5%
H
12.6
15.7
|
L
 -18.7%
H
10.0
19.6
|
L
 -35.4%
H
10.0
23.3
|
L
 -32.8%
H
10.0
26.0
|
L
H
10.0
32.8
|
L
H
10.0
32.8
|
L
H
10.0
32.8
|
L
H
10.0
32.8
|
Anteris Technologies Globa... |
|
88.8
|
2.5
|
L
 -16.0%
H
2.4
3.1
|
L
 -23.3%
H
2.4
3.3
|
L
 -66.5%
H
2.4
7.9
|
L
 -58.3%
H
2.4
8.8
|
L
H
2.4
8.8
|
L
H
2.4
8.8
|
L
H
2.4
8.8
|
L
H
2.4
8.8
|
Beta Bionics Inc. |
|
472.9
|
10.9
|
L
 2.1%
H
9.8
10.9
|
L
 10.1%
H
8.9
11.9
|
L
 -27.4%
H
8.9
17.1
|
L
H
8.9
24.5
|
L
H
8.9
24.5
|
L
H
8.9
24.5
|
L
H
8.9
24.5
|
L
H
8.9
24.5
|
Wellgistics Health Inc. |
|
150.1
|
2.9
|
L
 -26.1%
H
2.8
4
|
L
 -29.7%
H
2.8
4.7
|
L
 13.8%
H
2.4
5.7
|
L
H
2.3
5.7
|
L
H
2.3
5.7
|
L
H
2.3
5.7
|
L
H
2.3
5.7
|
L
H
2.3
5.7
|
Kestra Medical Technologie... |
|
1,246.0
|
24.3
|
L
 0.3%
H
22.1
24.6
|
L
 1.2%
H
21.5
25.0
|
L
 15.2%
H
20
26.1
|
L
H
20
26.1
|
L
H
20
26.1
|
L
H
20
26.1
|
L
H
20
26.1
|
L
H
20
26.1
|
Sanuwave Health Inc |
|
255.8
|
29.9
|
L
 2.2%
H
28.5
30.2
|
L
H
|
L
H
|
L
H
|
L
H
|
L
H
|
L
H
|
L
H
|